Effect of Statin Use on Acute Kidney Injury Following Elective Cardiothoracic Surgery: A Population Cohort Study in Denmark : 1
Perioperative Utilization of Statins in Patients Undergoing Intermediate to High Risk Non-Cardiac Surgery : 2
Pattern of Risks of Rheumatoid Arthritis among Patients Using Statins: a Cohort Study with the Clinical Practice Research Datalink : 3
Statin Use and Cholesterol Levels among US Adults with Age-Related Macular Degeneration (AMD): Findings from the 2005-2008 National Health and Nutrition Examination Survey (NHANES) : 4
Statin Initiation in a Closed Cohort of U.S. Women over Two Decades : 5
Pharmacoepidemiologic and In Vitro Evaluation of Potential Drug-Drug Interactions of Sulfonylureas with Fibrates and Statins : 6
Does a Risk Management Plan Increase Safety Monitoring for the Use of Tumor Necrosis Factor-alpha Inhibitors? : 7
Cost-Efficacy of Biologic Therapies for Moderate to Severe Psoriasis from the Perspective of the Taiwanese Healthcare System : 8
Regional Differences in Utilisation of Biologicals in Portugal : 9
Risk of Incident Heart Failure among Established Rheumatic Arthritis Patients Treated with TNF-alpha Inhibitors in Taiwan : 10
Development of an Algorithm to Identify Denosumab 60 Milligram Users in Health Insurance Claims Data : 11
Payer-Level Differences in the Response to Regulatory Actions Regarding Bevacizumab : 12
Antipsychotics and Mortality: Adjusting for Mortality Risk Scores to Address Confounding by Terminal Illness : 13
Mediators of the Causal Pathway to Mortality in Older Adults Who Use Antipsychotics : 14
Concomitant Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) during Antipsychotic Treatment in Incident Cases of Schizophrenia and Risk of 1-Year Psychiatric Hospitalizations : 15
Incidence of Weight Gain with Seroquel XL™ in Primary Care in England: Results from an Observation Post-Marketing Cohort Study : 16
Detecting Potential Adverse Reactions of Sulpiride in Schizophrenic Patients by Prescription Sequence Symmetry Analysis : 17
Course and Outcome of Clozapine Treatment in Patients with Incident Schizophrenia in Denmark : 18
Improving Empirical Variable Selection in Propensity-Score Models with High-Dimensional Covariate Space Using Healthcare Databases : 19
Penalized Regression for Fitting High Dimensional Propensity Score Models in Small Samples : 20
Improving Propensity Scoring through Machine Learning : 21
Propensity Score Matching and Unmeasured Covariate Imbalance: A Simulation Study : 22
Use of Propensity Score Methodology to Assess Comparability of Treatment Groups in a Registry Program : 23
Applying High Dimensional Propensity Score (HDPS) in a Exploratory Data Analysis with a US Claims Database for Recent Medicinal Products : 24
Increased Risk of Hip Fracture Associated with Dually-Treated HIV/Hepatitis B Virus Coinfection : 25
Antiretroviral Adherence among Patients Enrolled in an AIDS Drug Assistance Program : 26
Adherence to Antiretroviral Drugs and Its Determinants among Human Immunodeficiency Virus(HIV) Patients Attending HIV Clinic in a Teaching Hospital in Nigeria : 27
Predictors of Receiving Guideline Recommended Antiretroviral Treatment: Type of Provider Influences the Provision of Optimum HIV Treatment : 28
Seasonal Variation in Penicillin Use in Brazil and Mexico: An Analysis of the Impact of Over-the-Counter Regulations : 29
The Effects of Obesity on the Comparative Effectiveness of Linezolid and Vancomycin in MRSA Pneumonia : 30
Use of Triptans and Risk of Hemorrhagic Stroke in Women : 31
Women's Perception of Risks in Pregnancy : 32
Procedure-Related Issues Associated with the Nexplanon Contraceptive Implant: Interim Results from the Nexplanon Observational Risk Assessment Study (NORA) : 33
Unwanted Pregnancies in Women Using Intrauterine Devices: Final Results from the EURAS-IUD Study : 34
Rates of Opioid-Managed Pelvic Pain after Sterilization by Implanted Device vs. Tubal Ligation, U.S. 2005-2011 : 35
Persistent Opioid Use Following Cesarean Delivery: Patterns and Predictors among Opioid Naïve Women : 36
Antibiotic Use among Dutch Pregnant Woman and the Development of Toddler Asthma: the Influence of Confounding : 37
Genital Herpes Infection and Its Treatment in Relation to Preterm Delivery among 662,913 Births : 38
Erythromycin in Early Pregnancy and Fetal Safety: A Register Based Nationwide Cohort Study : 39
Antiepileptic Drug Use before, during and after Pregnancy: A Study in 7 European Regions : 40
Medications and Other Risk Factors for 2nd and 3rd Degree Hypospadias in the National Birth Defects Prevention Study, 1997-2009 : 41
Statins during Pregnancy and the Risk of Congenital Malformations: A Cohort Study : 42
Validation of Pancreatic Cancer Diagnosis Claims Within SEER-Medicare : 43
An Analysis of Biomarker Testing and Appropriate Treatment Among Women with Breast Cancer Using Oncology EMR Data : 44
Comparative Persistence to Oral Hormonal Agents in Women with Breast Cancer : 45
Elderly Breast Cancer Patient's Pill Burden and Adherence to Hormonal Therapy : 46
The Impacts of Competing Risks on Assessing the Association between Switch and Interruption of Adjuvant Hormone Therapy in Breast Cancer Women : 47
Prognostic Impact of Tumor MET Expression among Patients with Stage IV Gastric Cancer: A Danish Cohort Study : 48
Comparative Effectiveness of Drug-Eluting Stents for Patients with Coronary Diseases: A Nationwide Population-Based Study in Taiwan : 49
Real-World Effectiveness of Primary ICDs Implanted during Unplanned Medicare Hospitalizations : 50
Concomitant Use of Clopidogrel with Calcium Channel Blockers and Cardiovascular Outcomes in Patients Received Percutaneous Coronary Intervention : 51
Integration of Healthcare Delivery System Characteristics into Pharmacoepidemiologic Research: An Analysis of Acute Stroke Care Effectiveness : 52
Preadmission Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and 30-Day Stroke Mortality : 53
Severe Malabsorption Associated with Olmesartan: A French Nation-Wide Cohort Study : 54
Instrumental Variable Analysis Using Multiple Databases: An Example of Antidepressant Use and Risk of Hip/Femur Fracture : 55
Using Simulation to Explore the Properties of IV Bias Amplification and Unmeasured Confounding : 56
Instruments and Doubly Robust Estimation: Bias and Efficiency Compared to Conventional Estimators : 57
Evaluating Different Physician's Prescribing Preference Based Instrumental Variables in the Study of Beta2-Agonist Use and the Risk of Acute Myocardial Infarction : 58
The Performance of Different Disease Risk Score Methods for Estimating Unbiased Odds Ratio in the Presence of Multiple Confounders : 59
Accounting for Cumulative Exposure Effects in Comparative Effectiveness and Safety Analyses : 60
Use of Antidepressants and Age: A Comparatively High Risk of Suicide Attempts but Not of Suicide among the Young : 61
Drug Use Patterns and Characteristics of Elderly Users of Antidepressants in Germany : 62
Treatment Patterns among US Veterans Treated with Selegiline Transdermal System : 63
Neighborhood Material and Social Deprivation and Adherence to Antidepressant Treatment in Depression : 64
Understanding Inconsistent Results from Observational Pharmacoepidemiological Studies: the Case of Antidepressant Use and Risk of Hip Fracture : 65
(Non)availability of Dosage Instructions in Electronic Health Care Databases and Exposure (mis)classification: the Example of Antidepressants : 66
A Paradigm Shift for Screening Individual Case Reports: Accounting for Quality and Content : 67
Sequential Analysis After a Signal in Safety Surveillance of Drugs or Vaccines : 68
Comparative Analysis of Pharmacovigilance Systems in Five Asian Countries : 69
SAFEGUARD Results: Analysis of Pharmacovigilance Databases : 70
Beyond Traditional “Observed Versus Expected” Analyses: A Sensitivity Analysis Integrating Uncertainties Around Reporting Bias and Background Incidence Rate : 71
Validation of Signal Impact Assessment Tool in Order to Explore Pharmacovigilance Signals’ Follow-Up Actions : 72
A Guide to Guidelines. A Symposium Sponsored by the Public Policy Committee : 73
Academic Detailing: Putting Pharmacoepidemiology into Practice : 74
Biospecimens From Asia in Pharmacoepidemiology Research: Opportunities and Challenges in a Global Environment : 75
Challenges in Risk Minimization Evaluation: CIOMS Working Group IX Consensus and Recent Field Experience : 76
Gender Differences in Pharmacoepidemiology : 77
Impact of Methodological Choices on Findings from Pharmacoepidemiological Studies: Final Results of the IMI-PROTECT (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) Project : 78
The New ISPE Vaccine Special Interest Group (VAXSIG): Helping to Advance the Global Vaccine Agenda : 79
Risk of Hip Fractures Associated with Benzodiazepines: Applying Common Protocol To a Multi-Database Nested Case-Control Study. The PROTECT Project : 80
Effect of Allopurinol on Cardiovascular Outcomes in Hyperuricemic Patients: A Cohort Study : 81
Opioids and Breast Cancer Recurrence: A Danish Population-Based Cohort Study : 82
Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD Study : 83
Prevalence of Potentially Inappropriate Medication Prescribing Among Older US Adults Using STOPP Criteria : 84
Use of Antipsychotics and Risk of Acute Respiratory Failure in COPD: A Case-Crossover Study : 85
A Prospective Multicenter Study of the Incidence of Adverse Drug Events in Saudi Arabia: The (ADESA) Study : 86
Understanding Pharmacy Compounding in the Retail Setting: Practice and Role of Pharmacists in Singapore : 87
Is There Geographic Variation of the Frequency and the Profile of Adverse Drug Reactions? : 88
Rates of Opportunistic Infections in Psoriatic Arthritis Patients Compared to Non-Psoriatic Arthritis Patients : 89
Increased Benzodiazepine Abuse Among HIV-Infected Individuals in the United States : 90
Disease Burden of Hospitalized Influenza Patients: A Database Analysis in 2007 – 2012 : 91
Etiologic Features of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) with Ocular Involvement : 92
Childhood Atopic Dermatitis and Antidepressant Drug Use in Young Adults: A Nationwide Population-Based Cohort Study : 93
Epidemiology of Hepatic Impairment among Diabetes Patients in Japan : 94
Prevalence and Demographic Characteristics of Acromegaly in the United States : 95
Health Outcomes for Older Australians After Transient Ischaemic Attack (TIA) or Ischaemic Stroke (IS) : 96
Cataract in Cystic Fibrosis Patients : 97
Longitudinal Analysis of Dengue Fever Infections Reported in the UK between 2002 – 2013 Using the Health Improvement Network (THIN) Primary Care Database : 98
Regional Variation in Serum Urate amongst Patients Recruited for the Febuxostat Versus Allopurinol Streamlined Trial (FAST) : 99
Prevalent Conditions among Elderly and Non-Elderly Patients with Type 2 Diabetes (T2DM) : 100
Incremental Direct and Indirect Cost of Untreated Vasomotor Symptoms (VMS) : 101
Clinical Characteristics of Patients with Lupus Nephritis : 102
Epidemiology of Parkinson's Disease in China : 103
Adverse Drug Events in Medical and Surgical Patients of an Academic Hospital : 104
Severity and Patient Reported Outcomes of Dry Eye Disease in Taiwan : 105
Global Incidence of Acute Lymphoblastic Leukemia, 2003-2007 : 106
Prescriptions, Nonmedical Use and Emergency Department Visits of ADHD Stimulants : 107
Medical Comorbidities and Drug Utilization of Sickle Cell Disease Patients in a Large US Health-Claims Database : 108
Risk Modification of Dementia in Patients Aged ≥75 Years - Influence of PPIs : 109
The Inappropriate Prescribing of Antibacterial Medicines in Sudan; a National Study at National Health Insurance Fund Setting : 110
Predictors of G-CSF Prophylaxis in the First Cycle of Chemotherapy in Non-Hodgkin's Lymphoma Patients : 111
Do Case-Only Designs Yield Consistent Results Between Them and Across Different Databases (DB)? Hip Fractures Associated with Benzodiazepines (BZD) as a Case Study : 112
Use of Antidepressant Medications in Depressed Older Adults and Predictors of Discontinuation of Antidepressant Use : 113
Therapeutic Inertia and Intensified Treatment in Diabetes Prescription Patterns: A Nationwide Population-Based Study : 114
AHRQ/HCUPNet-Derived Pharmacoepidemiologic Evidence on Ventilation-Associated Iatrogenic Pneumothorax : 115
Disparities in Oral Antidiabetic Agents for Newly Diagnosed Type 2 Diabetes in Taiwan : 116
Differential Healthcare Utilization in Metformin Versus Sulfonylureas Users Pre- and Post-Initiation : 117
The Pattern and Prescription Cost of Diabetes in a Municipal Hospital in Ghana : 118
Treatment Patterns and Comorbidities in Adult Patients Treated for Gaucher Disease in the US : 119
Anti-Diabetic Medication Pattern during Inpatient Care for Patients with Diabetes in West China Hospital : 120
Three Years Antibacterial Consumption in the Indonesian Public Primary Health Care Center: The Aplication of ATC/DDD and DU90% Method To Monitor Antibiotic Use : 121
Using Drug Case Studies for Individual Case Management to Enhance Appropriateness of Vancomycin and Amikacin : 122
Inappropriate Initial Dosing of Fluconazole in Patients with Candidemia : 123
Different Use of Antibiotics in Rural and Urban Regions in the Netherlands, an Observational Drug Utilization Study : 124
Perspectives and Experiences of Community Pharmacists about Antibiotic Dispensing in Riyadh, Saudi Arabia : 125
Systemic Antimicrobials Consumption and Expenditures in Russian Multi-Profile Hospitals: the Results of Multicenter Trial : 126
Comparison of Outpatient Antibiotic Use Between Portugal and 5 European Countries in 2012 – There Is (Much) Room for Improvement! : 127
Empirical Antimicrobial Therapy or Directed To Hemoculture and Mortality in Patients with Sepsis in ICU: A Retrospective Cohort : 128
Analysis of Prescriptions Before and After Intervention of Evidence-Based Drug Formulary in Private Hospital in South Sumatra, Indonesia: A Quasi-Experimental Study : 129
Endocrine Therapy for Breast Cancer Patients in South Africa : 130
Utilization Trends of Anti-Tumor Necrosis Factor Therapy in Taiwan : 131
Trends in the Use of Maintenance Immunosuppressive Drugs among Liver Transplant Recipients in Taiwan: A Nationwide Population-Based Study : 132
Utilization Evaluation of Anticancer Drugs as Adjuvant and Neo-Adjuvant Therapy in the Management of Breast Cancer: A Study from a Developing Country : 133
Persistence on Disease Modifying Anti-Rheumatic Drugs Among Taiwan Established Rheumatoid Arthritis Patients : 134
Outpatient Use of Oral Anticancer Drugs in the Permanent Sample of the French Healthcare Insurance Database (2006-2011) : 135
Safety and Efficacy Conversion from Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Adavagraf) in Stable Liver Transplant Recipients : 136
Blood Cell, Renal and Liver Function Monitoring among Psoriasis Patients Who Initiated Methotrexate Use in Taiwan : 137
Treatment Patterns for Anemia among Breast Cancer Patients Treated with Chemotherapy in 2000-2013 : 138
Treatment Patterns for Anemia among Patients with Non-Hodgkin Lymphoma Treated with Chemotherapy in 2000-2013 : 139
Utilisation and Baseline Risk of Bleeding in Patients Prescribed Rivaroxaban: Interim Results from a Post-Marketing Observational Cohort Study : 140
Trends in Cardiovascular Risk Factors and Change over Time across Education Levels, and the Influence from Medicine Use and Gender. The Tromsφ Study 1994-2008 : 141
Drug Utilization Studies of Antihypertensive Drugs for Hospitalized Patients with Hypertension in Shenyang : 142
Utilization of Oral Anticoagulants in Patients with Non Valvular Atrial Fibrillation : 143
Withdrawn by Author : 144
Pharmacoeconomic Aspects of Angiotensin II Receptor Blockers in Patients with Essential Hypertension : 145
Preadmission Use of Calcium Channel Blockers or Beta-Blockers and 30-Day Stroke Mortality : 146
Effects of Pitavastatin on Glucose and Lipid Metabolism in Nondiabetic Patients in a Taiwan Medical Center : 147
Calcium Channel Blockers and Gingival Overgrowth: An Intensive Pharmacosurveillance Monitoring in Chiang Mai, Thailand : 148
Adverse Drug Reaction Reports for Cardiometabolic Drugs from Sub Sahara Africa: A Study in VigiBase : 149
The Use of Pillbox and Time in Therapeutic Range Among New Users of Warfarin: A Propective Cohort Study : 150
Excellent Outcome of Intensive Medical Care for Type B Aortic Dissection – A Single-Center Retrospective Study : 151
A Population-Based Study of the Drug Interaction between Clarithromycin and Statins : 152
Regional Variations in Physician Case Volume and Outcomes for Carotid Artery Stenting (CAS) vs. Carotid Endarterectomy (CEA) : 153
Treatment with Statins and Fibrates in Chinese Type 2 Diabetes Mellitus Patients Initiating Hospitalization at the Qingdao Endocrine and Diabetes Hospital from 2006 to 2012 in Qingdao, China : 154
Evaluation for Statin Usage in Taiwan by Using National Health Insurance Claim Database : 155
Patterns of Chronic Use of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Pre-Dialysis Chronic Kidney Disease Patients with Anemia : 156
The Incidence of Actinic Keratosis and Risk of Non-Melanoma Skin Cancer in Taiwan : 157
Compliance with Pregnancy Prevention Recommendations in 7,663 French Women of Childbearing Age Exposed to Acitretin : 158
Utilization Pattern of Phosphodiesterase Type 5 (PDE5) Inhibitors for Erectile Dysfunction among Commercially Insured Adults in the United States : 159
A Survey on the Utilization Pattern and Adverse Events of Oral Contraceptives in Korean Women Aged 20 to 49 Years : 160
The Risk of Major and Any (non-Hip) Fracture after Hip Fracture in the United Kingdom: 2000 – 2010 : 161
Use of Non-Steroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects with Type 2 Diabetes Mellitus : 162
Comparing Prescribing Pattern between Bisphosphonate and Raloxifene in Osteoporosis Patients : 163
Research on Asian Psychotropic Prescription Patterns for Antidepressants II: REAP–AD 2013 : 164
The Insomnia Treatment, Drug Usage and Their Side Effects in Taiwan: Analysis of 2009-2011 Nationwide Health Insurance Database : 165
Resource Utilisation of Patients with Alzheimer's Disease in Taiwan : 166
Use of Psychotropic Medication for People with Learning Disability or Autism in England: A Descriptive Study Using the Clinical Practice Research Datalink : 167
Disease Progression, Treatment Patterns, and Outcomes in Schizophrenia Over a 3-Year Period: Results from the Cohort for the General Study of Schizophrenia (CGS) : 168
Factors Associated with the Use of Pain Management-Related Medications among the Non-Cancer Elderly Patients Ever Utilized Traditional Chinese Medicine Services: A Retrospective Population-Based Cohort Study : 169
Association between Antipsychotic Treatment and Risk of Hip Fracture in Subjects with Schizophrenia : 170
Healthcare Utilization Prior to Self-Poisoning: Variation by Age and Gender : 171
Differences in ADHD Medication Usage Patterns in Children and Adolescents from Different Ethnic Backgrounds in the Netherlands : 172
Evaluating the Safety of Atypical Antipsychotic Drugs among Patients in Jos University Teaching Hospital : 173
Trends in Volume and Mortality in Carotid Endarterectomy (CEA) After Introduction of Carotid Artery Stenting (CAS) in Medicare Population : 174
Drug Use Patterns of Elderly Neuroleptic Users in Germany : 175
Characteristics of Patients with Depression Who Initiate Antidepressant and Benzodiazepine Therapy Simultaneously, Compared with Antidepressant Monotherapy : 176
Follow-Up of Psychoactive Drug Use in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada) : 177
Characterization of Potential Pharmacodependence of Zolpidem, Zopiclone and Zaleplone Users : 178
Testing the Robustness of Background Knowledge Confounder Selection in a Case-Control Study : 179
The Effect of a Comprehensive Approach to Blood Product Management: Automated Decision Support, Education, and Feedback : 180
Medication and Patient Safety in a Community Teaching Hospital : 181
The Association between Long-Term Bisphosphonate Use and the Risk of Fracture among Females with Osteoporosis in Taiwan : 182
Evaluate the Effectiveness of Preventive Medicine Curriculum among Medical Students of Public Universities in Malaysia : 183
Evaluate the Effectiveness of Preventive Medicine Curriculum among Pharmacy Students of Private Universities in Malaysia : 184
Are Prescription Drugs Substitutes for Inpatient Services? Evidence from Medicare Part D : 185
Misuse, Abuse, and Diversion of Instanyl® (Fentanyl Nasal Spray) in France : 186
Is Preventive Medicine Curriculum among Medical Students of Private Universities in Malaysia Effective? : 187
The Utilization Pattern of Glucocorticoids in Taiwan Established Systemic Lupus Erythematous Patients : 188
Evaluating the Impact of the Utah Clinical Guidelines on Prescribing Opioids for Treatment of Pain in Utah : 189
Examining the Impact of the Utah Opioid Guideline Based Intensive Educational Intervention on Opioid Prescribing in Utah : 190
Use of Bipolar Disorder Medications Prior to Diagnosis : 191
Assessment of Appropriateness and Safety of Dihydroergotoxine Use : 192
The Utilization and Safety of Abraxane® for the Treatment of Metastatic Breast Cancer in the USA: Results from Health Insurance Claims Data : 193
Patterns of Analgesic Initiation among Hemodialysis Patients : 194
Prevalence of Inappropriate Prescribing of Inhaled Corticosteroids for Respiratory Tract Infections in the Netherlands : 195
Impact of Tuberculosis Treatment on Health-Related Quality of Life of Pulmonary Tuberculosis Patients: A Follow-Up Study : 196
Characteristics Associated with Use of Oral or Inhaled Respiratory Medications at Initiation for Patients with Chronic Obstructive Pulmonary Diseases : 197
Changes in Drug Prescriptions After the SMART Trial – Secondary Data Analysis of Bavarian Asthma Patients : 198
Changes in Thiazolidinedione Utilization and Outcomes Following Safety Warning and Risk Evaluation & Mitigation Strategies (REMS) in Taiwan : 199
The Prescribing Pattern of Postnatal Steroids on Preterm Infants in Taiwan : 200
Prescribing of Drugs in the Therapy of Acute and Chronic Pain in Family Medicine Practice in Croatia : 201
Utilization and Government Cost of Antisecretory Drugs among Elderly in Australia and New Zealand : 202
Hospital Length of Stay for Patients with Acute Myocardial Infarction in China : 203
Hospital Registry of Stroke or Transient Ischemic Attack (LIS-2). Design and Prehospital Medical Treatment Analyses : 204
The Efficacy and Safety of Liraglutide for Patients with Type 2 Diabetes Mellitus in Changhua County, Taiwan : 205
Adherence to Treatment Guidelines in Type 2 Diabetes (T2DM) Patients Treated with Metformin (MET) Monotherapy with Suboptimal Glycemic Control in Israeli Managed Care : 206
Geriatric Homecare Patients’ Awareness on the Side-Effects of NSAID Abuse : 207
The Impact of Diabetes on Mortality in Non-ICU Inpatients from a Chinese Tertiary Hospital : 208
Drug Safety Education among Outpatient Using Teriparatide:Improving Patients Care : 209
A Pilot Analysis of a Pharmacist Initiated Home Medication Review Programme with Type 2 Diabetes Patients in Penang, Malaysia : 210
Predictors of Prescription Drug Importation by United States Adults : 211
Prevalence and Treatment of Pain in Emergency Departments in the United States, 2000-2010 : 212
Continuous Use of Medicines: Pattern and Characteristics Associated among Participants of the ELSA-Brasil Study : 213
Regional Variation in Strong Opioid Prescribing in UK Primary Care Settings : 214
Attitudes in Antidepressants Use in Greece : 215
Asthma Prevalence and Utilization of Antiasthmatic Drugs among All Children in Stockholm, Sweden : 216
Bone Density Screening and Reduced Risk of Hip Fracture: Effectiveness or Confounding? : 217
Long Term Usage of Opioids by Chronic Intractable Non Cancer Pain Patients in TAIWAN from 2003 to 2012 : 218
Over-the-Counter Aspirin Use, Comorbidities, and Timing of Aspirin Therapy Initiation in Multiple Myeloma Patients : 219
Ophthalmologists Practice Patterns on Performing Intravitreal Injections in Europe : 220
Temporal Changes in Polypharmacy, Hyperpolypharmacy and Exposure to Anticholinergic and Sedative Drugs: A Five-Year Study of Community-Dwelling Older Men : 221
The Validity of a Patient-Reported Adverse Drug Event Questionnaire Using Different Recall Periods : 222
Analyzing the Short-Term Social Media Impact of a Drug Safety Publication-A Case Study Approach : 223
A Qualitative Study Exploring Perspectives towards Generic Medicines among Medical Specialists and Consultants at a District Hospital in Malaysia : 224
Practices and Self Confidence towards Antibiotic Prescribing: An Exploratory Study Focusing Prescribers in the District of Kota Setar, Kedah, Malaysia : 225
A Qualitative Study Exploring Perspectives towards Generic Medicines among Medical Specialists at a District Hospital in Malaysia : 226
Prescribing Drug Use and Costs among Adult Outpatients with Type 2 Diabetes in Taiwan: A Nationwide Population-Based Study : 227
Drug Discrepancy and Medication Error of Admitted Patients by Medication Reconciliation Process : 228
Drug-Related Hospital Readmission in Community Hospital, Thailand : 229
Post Authorization Safety Studies (PASS): Application of Prospective Observational Study Methodology : 230
European Drug Lists for Integration in a Decision Support Tool for Optimization of Drug Therapy in Older Persons : 231
Registry: Its Use in Real-World Data Collection : 232
Post Authorization Safety Studies (PASS): Application of Retrospective Chart Review Methodology : 233
Utilization Trend and Management of Oral Anticancer Medicines Using Nationwide Pharmacy Database and Questionnaire Survey at Pharmacies in Japan : 234
Novel Methods of Adverse Event Detection Using Electronic Health Record Data: A Critical Review of the Literature : 235
Associations of Drug Burden Index with Falls, General Practitioner Visits, and Mortality in Older People : 236
Drug Utilization Pattern for the Treatment of Septic Shock in the ICU: A Comparison between Survivors and Non-Survivors in a Tertiary Care Teaching Institute : 237
Development of Pharmacy-Based Patient Registry for Long-Term Medication Use Monitoring : 238
The Incidence of Adverse Drug Events among the Critically Ill Patients: A Prospective Multicenter Study : 239
Drug Use Study of Heparin Using Japanese Claim Data of Inpatients : 240
Utilization and Predictors of Ophthalmic Steroids in Patients with Dry Eye Disease: A Nationwide Population-Based Study in Taiwan : 241
Longitudinal Changes of Polypharmacy in the Elderly: A Population-Based Study over a 10-Year Period in Taiwan : 242
Find the Risk of Drug Usage from the Surveillance Results of the Electronic Media Advertisements : 243
Use of Ezetimibe in Australia : 244
Appropriate Prescribing of Medications among Diabetic Medicare Patients Treated by Nurse Practitioners or Physicians : 245
Using Routinely Collected Administrative Health Claims Data to Improve the Uptake of Primary Healthcare Services : 246
Assessment of Clinical Features and Medical Treatment of Patients with Atrial Fibrillation in Outpatient Registry in Moscow : 247
Do Rational Use Meet Reality in a Country Under Financial Assistance Program for Cost-Saving Expenditures? The Two Sides of the Portuguese Coin : 248
Surveillance of New Drug Adoption in Australia Using Primary Care EHR Data : 249
Sex Differences in Utilization of Nervous System Drugs in Sweden and Taiwan : 250
Evaluation of Control Activities of Antibiotic Prescribing Practices and Multidrug-Resistant Bacteria in Healthcare Organizations of Paris City and Inner Suburbs : 251
Analysis of Essentiality of the Medicines from the “Popular Pharmacy Program in Brazil” : 252
Influenza Vaccination According to Dementia Diagnosis in French Nursing Homes : 253
Sex, Gender and Drugs – A Tool for Gender-Conscious Prescribing : 254
Comparison of Medication Use in Taipei with Non-Taipei City by Beers Criteria in Elderly Based on the National Health Insurance Research Database in Taiwan : 255
Erythropoietin Stimulating Agent Prescribed Pattern for the Incident Uremia Patients in Taiwan : 256
Using Administrative Healthcare Data to Study the Treatment of Inflammatory Bowel Disease in the Region of Stockholm, Sweden : 257
An Audit of Prescriptions from the Dental Outpatients Department of a Tertiary Hospital in Ado-Ekiti, South-West Nigeria : 258
Medication Utilization in the Palestine Refugee Population in the Middle East: A Cross-Country Comparative Analysis : 259
Psychotropic Utilization in Ribeirao Preto, Brazil : 260
Rational Usage of Medicines at the Public Heath Facilities in Rajasthan, India : 261
Interactions between Pharmaceutical Company Representatives and Physicians in Jos, Nigeria : 262
What Makes Prescribers Switch to Fixed-Dose Combination Therapy for Japanese Hypertensive Patients? : 263
Investigation of Drug Safety Information of Ethnic Medicine from 622 Drug Instructions in Guizhou : 264
Persistence Rate and Adherence Level To Oral Antidiabetics and Their Associated Determinants : 265
Investigating Time-Varying Factors Associated with Lipid Lowering Medications for Primary CVD Prevention Using Multistate Markov Modeling : 266
Dimension Reduction and Shrinkage Methods for Improving High Dimensional Disease Risk Score Estimation in a Historical Cohort : 267
Diabetogenic Effects of Atypical Antipsychotics – Exploration of Measurement Bias : 268
Construction of Treatment Episodes in Elderly Neuroleptic and Antidepressant Users : 269
Manual Versus Automated Coding of Free-Text Self-Reported Drug Use in the 45 and Up Study: A Validation Study : 270
Composite Testing in Pharmacovigilance: The Benefit of Window Shopping : 271
Evaluation of Analytical Method Performance Using Self-Controlled Case Series : 272
Application of Multivariate Statistical Methods to the Assessment of Drug Abuse Potential Based on Spontaneously Reported Adverse Events : 273
Health Outcomes and Medical Effectiveness Research (HOMER): A Systematic Approach to Exploring Hill's Causal Viewpoints in Observational Data : 274
Determination of Shrinkage Parameters in Spontaneous Reporting System in China : 275
Treating Analysis of Dose Flexibly Within a Post-Authorisation Safety Study of an Atypical Antipsychotic : 276
Performance of the High-Dimensional Propensity Score Algorithm When In-Hospital Medico-Administrative Data Are Unavailable : 277
Performance of Disease Risk Score Matching in Nested Case-Control Studies : 278
Strategies for Modeling the Relationship between a Biomarker and a Binary Outcome : 279
Covariate Balance When Matching on Disease Risk Scores in Cohort Studies : 280
Measurement Bias in Billing Data – A Simulation Study : 281
The Use of Complementary Medicines for HIV-Infected Children in Lagos, Nigeria : 282
Predictors of Broad Spectrum Antibiotics Use in Children in a Nigerian Hospital : 283
Determination of a Possible Association between Human Papillomavirus (HPV) Vaccination and Migraine : 284
Stimulant Effectiveness on Driving Citations and Crashes of Children with ADHD : 285
Antipsychotic Initiation and Stability of Foster Placement Among Youth with Disruptive Behaviors : 286
Long-Acting β2 Agonist Without Concomitant Inhaled Corticosteroids in Children with Asthma in Primary Care : 287
Healthcare Databases for Paediatric Studies: A Report from the GRiP Network Global Survey : 288
Off-Label Prescription in Pediatric Patients in Bandung City, Indonesia : 289
Epidemiology of Rotavirus Gastroenteritis (RGE) in Young Children in Rural Guangxi, China : 290
Adveras Effect of Reactions in Time of Hospital Stay and Delay in Pediatric Patients with Chemotherapy Leukemia : 291
PMSI Database Consultation: Evaluation of Hospital Stay Length for Infantile Haemangioma in France Previous To and Subsequent To Propranolol Use : 292
Medical and Economic Impact of Infantile Haemangioma in France Previous To Propranolol Use : 293
Infantile Haemangioma: A Burden for Families : 294
Adolescent Asthmatics’ Needs and Preferences Regarding Medication Counseling: Results from Online Focus Groups : 295
Pediatric Drug Safety Surveillance in Italian Pharmacovigilance Network: An Overview over the Years 2001-2012 : 296
Adverse Drug Reactions of Spontaneous Reports in Shanghai Pediatric Population : 297
Adverse Reactions in Children: French Data : 298
Inhaled Corticosteroids for Preschool Children – A Norwegian Register Study : 299
Serious Adverse Drug Reactions Associated with Pneumococcal Vaccine: Experience in Thailand : 300
Design of Randomized, Double-Blind, Controlled, Multi-Centre Phase IIb Trials as Part of the EU-Funded UNISEC Project to Assess the Safety, Immunogenicity and Clinical Efficacy of Cross-Seasonal Universal Influenza Vaccines with or Without Pandemic Influenza Vaccine in Healthy Adults : 301
Tolerability Survey of a Two-Dose Pandemic Vaccine [Focetria®], Administered after the Seasonal 2009-2010 Influenza Vaccination in the Netherlands : 302
Assessment of Vaccination Rates among Children Within the Humedica EHR Database, 2007-2013 : 303
Impact of Vaccine Effectiveness on Signal Detection Based on Disproportionality : 304
Detection and Validation Strategy of Herpes Zoster (HZ) Cases for a Vaccine Effectiveness Study in a Managed Care Organization Database : 305
Effectiveness of the 2009 Pandemic H1N1 Influenza Vaccines in Preventing H1N1 Infection: A Meta-Analysis : 306
Linkage of the Vaccination Registration Praeventis with the IPCI Medical Record Database in the Netherlands - A Pilot Study : 307
Safety of Rotavirus Vaccines: Analysis of Adverse Events Reported Under Reexamination System and Spontaneous Reporting System in Korea : 308
Adverse Events Following Rabies Pre- and Post-Exposure Prophylaxis in Taiwan, July–December 2013 : 309
The Association Between Pneumococcal Vaccine and Thrombocytopenia in Elderly Patients with Chronic Obstructive Pulmonary Disease: A Case-Crossover Study : 310
Uptake of Influenza Vaccination in Elderly People: Impact of Dementia Diagnosis : 311
Design and Feasibility of a Study Using the Clinical Practice Research Datalink General Practice OnLine Database (CPRD GOLD) To Assess the Risk of New Onset of Auto-Immune Diseases (NOAD) Following Administration of the Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine : 312
Impact of Right Truncation in Studies of Drug Safety during Pregnancy : 313
Comparative Safety of Depression Treatments in Late Pregnancy for the Neonate : 314
Teratogenicity of Selective Serotonin-Reuptake Inhibitors and Venlafaxine – A Population-Based Study of 2.3 Million Births in Five Nordic Countries : 315
Use of Antidepressants during Pregnancy and the Risk of Pregnancy-Induced Hypertension : 316
Use of Antidepressants and Induced Abortions: Population Based Case-Control Study from Three Nordic Countries : 317
Withdrawn by Author : 318
Electronic Health Data Capture of Clinical Evaluation and Pancreatic Cancer (PC) Diagnosis (DX) in Patients with Type 2 Diabetes (T2DM) : 319
Proteinuria Testing Among Patients with Diabetes Mellitus Is Associated with Bladder Cancer Diagnosis: Potential for Unmeasured Confounding in Studies of Pioglitazone and Bladder Cancer : 320
The Risk of Colorectal Cancer in Patients with Type 2 Diabetes: Associations with Treatment Stage and Obesity : 321
Colorectal Cancer Risk in Metformin Initiators – A Matched Cohort Study : 322
Duration of Metformin Use and Risk of Prostate Cancer in Men with Diabetes : 323
Exposure to Pioglitazone and Risk of the 10 Most Common Cancers : 324
Disparities in the Use of Prescription Medications: A Population-Based Approach : 325
Racial/Ethnic Disparities in US Prescribing Patterns of Sleep Medications from 1996-2010 : 326
Sex Differences in Utilization of Cardiovascular Drugs in Sweden and Taiwan : 327
Cross-National Comparison of Prescribing Patterns in Australian and Dutch Nursing Homes : 328
Bladder Antimuscarinics and Cognitive Decline in Elderly Patients Enrolled in the National Alzheimer's Coordinating Center Cohort : 329
Utilization and Predictors of Active Surveillance among Elderly Men with Low-Risk Localized Prostate Cancer : 330
Avoiding “Crystal Ball” Epidemiology: The Case of Low-Dose Aspirin and Major Bleeding : 331
AUDIT-C Alcohol Misuse Screening Score and Major Bleeding in Warfarin Therapy: An Evaluation of Main Effects and Interaction with VKORC1 Genetic Status : 332
An International Comparison of Spontaneous Adverse Event Reports and Potentially Inappropriate Medicine Use Associated with Dabigatran : 333
Intravenous Thrombolytic Therapy Is Beneficial for Acute Stroke Patients with Renal Dysfunction : 334
Adherence and Persistence to New-Users of Dabigatran Among Patients with Non-Valvular Atrial Fibrillation in an Administrative Claims Database : 335
Utilization of Anticoagulants in Atrial Fibrillation: Influences of Clinical Risk Scores in Real-World Practice : 336
Use of Pharmacologic Agents for the Secondary Prevention of Osteoporotic Fracture: A Cross-National Study : 337
Patterns of Pharmacological Treatment for Osteoporosis among Patients Qualified for Pharmacotherapy According to the National Osteoporosis Foundation Guidelines : 338
Distributed Analysis of Total Hip Arthroplasties Using Six International Registries: Comparing the Effects of Implant Bearing Surface and Size : 339
Shiny and New: Examining Patient and Physician Utilization of Non-Oral Osteoporosis Medications in Ontario, Canada : 340
Mortality in British Hip Fracture Patients, 2000 – 2010: A Population-Based Retrospective Cohort Study : 341
Medicine Use and the Risk of Hip Fracture in the Elderly: A Case-Crossover Study : 342
The Dual-Time-Adjusted Case-Crossover Design : 343
Adapting and Evaluating Self-Controlled Case Series Method (SCCS) for Signal Screening of a Recently Marketed Drug Using a US Claims Database : 344
The Use of Prior Event Rate Ratio Adjustment Method for Controlling Unmeasured Confounding in Pharmacoepidemiologic Studies: A Cautionary Note : 345
Controlling Time-Dependent Confounding by Frailty: Restriction Versus Statistical Adjustment : 346
Comparator Choice in Diabetes Drug Studies: Single Class or Non-User Comparator Group? : 347
Comparing Estimation Strategies for Disease Risk Scores: A Simulation Study : 348
Increasing Trend of Type 1 Diabetes in Dutch Children and Adolescents (1998-2010) : 349
Cancer Incidence among Infants in the United States, 2000-2010 : 350
Chronic Comorbidities in Children and Adolescents with Type 1 Diabetes : 351
Antimuscarinic Utilization in the Pediatric Population in the United States, 2000-2011 : 352
Prevalence of Pediatric Chronic Hepatitis C Patients in the European Union (EU) in 2012 : 353
Association between Use of Asthma Drugs in Children and Hepatotoxicity : 354
Use of Oral Contraceptives and Risk of Hemorrhagic Stroke in Denmark (2003 -2012) : 355
Comparative Cardiovascular Safety of Testosterone Formulations in the United States and United Kingdom : 356
Dipeptidyl Peptidase-4 Inhibitors Do Not Increase the Risk of Cardiovascular Events in Type 2 Diabetes : 357
Risk of Out-of-Hospital Sudden Cardiac Death with Use of Domperidone, Proton Pump Inhibitors, and Metoclopramide : 358
Association of Azithromycin and Ventricular Arrhythmia: the ARITMO Project : 359
Risk of Hemorrhagic Stroke Associated with Combined Use of Antidepressants and Non-Steroidal Anti-Inflammatory Drugs : 360
Comparison of Chronic Disease Burden of Chinese in US and in China: Findings from Two Large Nationally Representative Surveys in US and China : 361
Safety of Anticholinergic Medications in the Elderly: Anticholinergic Burden and Lower Urinary Tract Symptoms (LUTS) : 362
Oral Corticosteroids and the Risk of Serious Infections in Patients with Elderly-Onset Inflammatory Bowel Diseases : 363
Withdrawn by Author : 364
Incidence of Barrett's Esophagus and Esophageal Adenocarcinoma in the United Kingdom and the Netherlands: Did We Reach a Plateau? : 365
Incidence of Drug-Induced Acute Liver Failure: A Population-Based Study : 366
Identification of Type 2 Diabetes Mellitus in Different Electronic Databases Within the SAFEGUARD Project : 367
Identification of Prediabetes, Healthcare Utilization and Progression to Diabetes in CPRD : 368
Characteristics of Patients with Type 2 Diabetes (T2DM) Captured in Administrative Claims and Electronic Medical Records (EMR) : 369
Monitoring for Proteinuria in Patients with Type 2 Diabetes Mellitus in the U.K. Clinical Practice Research Datalink : 370
Characteristics of Patients with Type 2 Diabetes Starting Sitagliptin vs. Other Oral Diabetes Medications and Propensity Score Balance : 371
Baseline Characteristics of Patients with Type 2 Diabetes Initiating Sitagliptin or GLP-1 Receptor Agonists : 372
Comparison of Matching on Key Confounders, High-Dimensional Propensity Score (HDPS) and a Combination of Both to Adjust for Confounding : 373
Head to Head Comparison of the Propensity Score and High-Dimensional Propensity Score Matching Methods in Reducing Potential Indication Bias : 374
High-Dimensional Propensity Score Versus Lasso Outcome Regression for Confounding Adjustment : 375
Trimming on Propensity or Disease Risk Scores to Enhance Validity in the Design of Comparative Effectiveness Studies : 376
Antidepressant Use and Risk of Hip Fracture: A Comparison of Marginal Structural Models, Conventional Regression and Propensity Score Methods : 377
Preference and Propensity: Evaluating Oral Treatment of Type 2 Diabetes (T2DM) : 378
Do Patients Initiate Therapy? Primary Non-Adherence to Statins and Antidepressant in Iceland : 379
Patterns of Statin Prescribing for the Primary Prevention of Cardiovascular Disease in People with Severe Mental Illness : 380
Drug Utilization Pattern in Children with Autism Spectrum Disorder (ASD) in Asian Countries: A Population Based Study : 381
Withdrawn by Author : 382
The Impacts of Non-Adherence on Hospitalizations in Patients with Schizophrenia in Thailand : 383
Discontinuation of Somatic Medication during Psychiatric Hospitalisation : 384
Assessment of Prediabetes in the United Kindgom CPRD and Its Association with Incident Cancers : 385
Adherence to Drug Treatment: A Practical Look at Complex Measurement Issues : 386
Databases in China: Are We Ready Yet? : 387
Challenges in Implementing Findings of Regulatory Science to Evaluate and Improve the Drug Regulatory System : 388
Guidelines and Recommendations for Comparative Effectiveness Research (CER) Methods: International Assessment and Exchange : 389
Leveraging Electronic Health Data for Medical Device Epidemiology: Approaches To Post-Market Surveillance of Joint Replacement Surgery : 390
Primary Data Collection in Pharmacoepidemiology: Design, Practical, and Methodologic Considerations : 391
Tracking of Adverse Drug Reactions in Social Media: Current Status of Requirements, Best Practices, Methods and Tools : 392
Quantitative Benefit-Risk Assessment of the Quadrivalent HPV Vaccine for the Prevention of Anal Cancer in Males – Results : 393
Application of Targeted Maximum Likelihood Estimation in Pharmacoepidemiology : 394
Incidence of Gastrointestinal Perforation among Patients with Crohn's Disease and Those Patients Dispensed with Anti-TNF Therapy : 395
Idiopathic Thrombocytopenic Purpura After Seasonal Influenza Vaccination : 396
30-Year Mortality Following Venous Thromboembolism: A Population-Based Cohort Study : 397
Malignant Diseases in Swedish Person with Heamophilia-A Longitudinal Registry Study : 398
The Risk of Malignant Melanoma among Patients with Multiple Sclerosis : 399
Combining Information from an Electronic Healthcare Database and Spontaneous Reporting Database for Enhancing Signal Detection : 400
Preventable Drug Related Problems and Factors That Affect Heart Failure Treatment at Maharaj Nakorn Chiangmai Hospital : 401
Association between Generic Substitution and Refill Adherence to ACE-Inhibitors - Analysing the Impact of Using Multiple Medications : 402
Effect of a Medication Adherence Program for Long-Acting Injectable Atypical Antipsychotics on Adherence and Psychiatric Hospitalizations : 403
Associations between Generic Switch and Adherence - Do Patients’ Discomfort, Need of Information and Concerns about Medicine Influence Adherence: A Combined Cross-Sectional Questionnaire and Register Study : 404
Physician Adherence to Antihypertensive Drug Treatment Guidelines and Cost of Antihypertensive Drugs in Indian Setting : 405
Predictive Validity of Four Self-Reported Measures of Medication Adherence in Patients with Type 2 Diabetes : 406
Evaluation of Adherence To Therapy in Patients with Chronic Kidney Disease : 407
Factors Affecting the Regular Admission of Statins (according to the Register PROFILE) : 408
Barriers to Medication Adherence among Outpatients in Jos University Teaching Hospital : 409
A Medicines List Is a Simple Tool to Improve Adherence : 410
Association between Adherence to Secondary Prevention Therapies and Mortality in Acute Myocardial Infarction (AMI) : 411
The Investigation of Potential Prescription Medications Waste in a Medical Center: A Pilot Study : 412
HIV/AIDS Clinical Care Program Certification International: Pharmaceutical Care Model Established and Efficacy Analysis : 413
Pharmacist-Led Educational Interventions to Improve Inhalation Technique in Pediatric Asthma Patients : 414
Self-Reported Adherence To Antiretroviral Therapy in Sub-Saharan Africa: A Meta-Analysis : 415
Enriching Persistence Prediction Models Using Prior Adherence and Empirically Selected Claims Data Components : 416
Persistence to Osteoporosis Drugs Following an Incident Osteoporotic Fracture: the PREFRAC Study : 417
Efficacy and Content Analysis of Adherence Interventions to Enhance Oral Antidiabetic Adherence (OAD) in Adults with Type 2 Diabetes: A Systematic Review and Meta-Analysis : 418
The Impact of Two Consecutive Prescription Charges on Adherence to Chronic Medications in the Irish General Medical Services Population : 419
The Influence of Anxiety and Depression on Barriers to Antiretroviral Treatment Adherence Reported by People Living with HIV in Brazil : 420
Association between the Medicare Part D Coverage Gap and Non-Adherence to Hormonal Treatment for Breast Cancer : 421
Withdrawn by Author : 422
The Discrepancy of Perceived Medication Use Patterns among the Elderly from Patient-Related and Health Professionals’ Perspectives : 423
Consumption of Rosiglitazone and Pioglitazone Following Safety Warnings – A Time Series Intervention Analysis in Portugal : 424
Safety of Azithromycin Therapy in Patients with High Cardiovascular Risk. A Meta-Analysis of Randomized Controlled Trials : 425
Prevalence and Antimicrobial Resistance Pattern of Community Acquired Pathogens Against Beta Lactam Antibiotics Isolated from Residents of Holy Makkah, Saudi Arabia : 426
Prevalence and Antimicrobial Resistance Pattern of Community Acquired Pathogens Against Aminoglycoside and Quinolones, Isolated from 2 Emergency Settings from Multinational Patients, Holy Makkah, Saudi Arabia : 427
A Meta-Analysis of the Harms Associated with the Novel Oral Anticoagulants (NOACs) for Stroke Prevention in Atrial Fibrillation (AF) and the Treatment of Venous Thromboembolism (VTE) in the Elderly : 428
The Bleeding Risk with Warfarin-Based Antithrombotic Regimen among Acute Coronary Syndrome Patients with Atrial Fibrillation : 429
Increased Bleeding Risk of Dabigatran Usgae in Patient with Renal Impairment : 430
Low Body Mass Index Predictor for Dabigatran Related-Bleeding : 431
Improving the Use of Lipid Lowering Treatment in Primary Prevention: A Randomized Clinical Trial : 432
Estimate of Venous Thromboembolism and Related-Deaths Attributable to the Use of Combined Oral Contraceptives in France : 433
Are ECG Monitoring Recommendations before Prescription of QT Prolonging Drugs Applied in Daily Practice? The Example of Haloperidol : 434
Interferon β and Rate of Hospitalization Due to Infections among Multiple Sclerosis Patients : 435
Proportionality between Adverse Events Identified in Spontaneous Reporting Databases and Population-Based Estimates of Drug Exposure : 436
Health Care Professionals’ Knowledge and Attitudes of Drug Benefits and Risks in Africa : 437
Used of Potentially Inappropriate Medications among Older Outpatient with Long-Term Prescription at a Medical Center in Taiwan : 438
Validation of a Refined Health Related Quality of Life Comorbidity Index in Populations through Cross-Sectional Surveys : 439
Risk Factors of Colistin Nephrotoxicity and Severe Nephrotoxicity in the Clinical Setting : 440
Anti-Tuberculosis Drug Induced Liver Injury in a Regional Hospital : 441
Safety Information, Boxed Warning, and Contraindications in Drug Labeling: A Comparison of the USA, the UK, and Canada : 442
Deployment and Evaluation of the Doctor-Consulting System for Home-Care Cases (DSHC) in a Medical Center : 443
Inappropriate Prescribing Defined By Start and STOPP Criteria and Association with Adverse Drug Events in Elderly Hospitalized Patients : 444
How the Transparency Data Regulations Are Changing the Communication Regarding Benefit-Risk of Medications : 445
Useablity of Harm Profile Data in Product Descriptions: A Comparison between the US and Europe : 446
Evaluation of the Value of Web Data for Detecting Drug Adverse Events : 447
A Regulators’ Challenge: the Transfer of New Scientific Knowledge into Regulatory Practice. The Example of PROTECT : 448
Study of Medication Errors Which May Occur in the Process of Electronic Prescription and Dispensing Using Failure Mode and Effects Analysis (FMEA) : 449
Quantitative Benefit-Risk Assessment of the Quadrivalent HPV Vaccine for the Prevention of Anal Cancer in Males – Method : 450
The Application of the Columbia Classification Algorithm of Suicide Assessment (C-CASA) Algorithm to Evaluate Suicidal Ideation and Behaviour Within a Post-Authorisation Safety Study : 451
Comparative Quantitative Benefit-Risk Assessment of High- and Low-Dose Methylprednisolone in Multiple Sclerosis Relapse Management : 452
Simulation Modelling for Quantitative Benefit Risk: An Example of Comparative Harm for Glaucoma Treatment : 453
Effectiveness of Risk Minimisation Measures for Vandetanib in Canada: A Process and Outcome Evaluation : 454
The Timing of Safety Regulatory Decisions Compared with Cumulative Meta-Analysis’ Risk Estimates : 455
A Unified Framework for Classification of Methods for Benefit-Risk Assessment : 456
Drug-Drug Interaction Alerts in Hospital Setting: Distribution, the Prevalence of Overrides, and Prescriber Determinants : 457
Comparative Effectiveness Research of Metformin-Based Oral Hypoglycemic Therapy in Taiwan's Population-Based Database : 458
Effect of Body Mass Index on Choice of Initiating Diabetes Therapies : 459
Clinical Evaluation of Tigecycline in the Treatment of Nosocomial Infection in a Hospital in Taiwan : 460
Therapeutic Drug Monitoring and Pharmacogenetic Study of HIV-Infected Ethnic Chinese Receiving Nevirapine -Containing Antiretroviral Therapy : 461
Use of Granulocyte Colony-Stimulating Factor and Neutropenic Events among Breast Cancer and Non-Hodgkin's Lymphoma Patients : 462
A Retrospective Study of the Liver Transplantation Recipients for Finding Risk Factors of Post-Transplant Metabolic Syndrome (PTMS) : 463
Inverse-Probability-of-Selection Weighting of Rich Subsample Data Provides Informed Estimates of Treatment Effects for a Larger Sample : 464
Drug Safety Monitoring with a Self-Controlled Design and Time-Trend Adjustments Using Dabigatran and Warfarin as an Example : 465
Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes Mellitus – A Retrospective Cohort Study in Taiwan : 466
Association between Statin Use and Cardiovascular Mortality Decline at the Population Level in the Netherlands 1994-2010 : 467
Association between eGFR Decline and JNC7 Concordant Antihypertensive Treatment : 468
Comparative Efficacy and Safety of New Oral Anticoagulants Versus Vitamin K Antagonists: Rationale, Design and Baseline Characteristics of the NACORA-BR Observational Study : 469
Systematic Review of of Kudiezi Injection for Acute Cerebral Infarction : 470
Comparative Effectiveness of Different Oral Antibiotics Regimens for Treatment of Urinary Tract Infection in Outpatient Settings-A Cohort Study on National Healthcare Administrative Database : 471
Looking Both Ways Before Using the Disease Risk Score (DRS): Performance of the DRS in a Cohort with Known Selection Bias : 472
Effect of Conventional Enzyme-Inducing Antiepileptic Drugs on Cancer Mortality and Survival: An Exposed-Unexposed Study of Carcinoma Breast and Glioblastoma Multiforme : 473
Effectiveness, Tolerability and Impact on Quality of Life of Interventions Used for the Management of Patients with Chronic Low Back Pain : 474
Anticonvulsants or Antidepressants in Combination Pharmacotherapy for the Treatment of Neuropathic Pain in Cancer Patients: A Meta-Analysis : 475
Medication and Risk of Rehospitalization in Bipolar Disorder: A Nationwide Cohort Study : 476
Proton-Pump Inhibitors Do Not Impair (and May Modestly Help) Metformin's Effectiveness : 477
Preference-Based Instrumental Variable (IV) Methods in the Comparative Effectiveness of Osteoporosis (OP) Medications in Women with Postmenopausal Osteoporosis (PMO) Using the MarketScan Database : 478
Effect of Anti-Inflammatory Treatment on Depression and Side Effects: A Systematic Review and Meta-Analysis of Randomized Clinical Trials : 479
Comparison of Re-Hospitalization and Emergency Room Visit Patterns Among Patients with Schizophrenia Receiving Paliperidone Palmitate or Oral Atypical Antipsychotics in an Inpatient Setting : 480
Above Standard Dose of Octreotide-LAR in Patients with Neuroendocrine Tumors (NET) for Control of Carcinoid Syndrome Symptoms: A Multi-Center Retrospective Chart Review Study : 481
Vildagliptin Efficacy in Combination with MetfoRmIn for EarlY Treatment of Type 2 Diabetes Mellitus (VERIFY) : 482
Exploring the Factors Associated with Self-Report of Health Status among the Elderly Diagnosed with Chronic Respiratory Diseases in Taiwan : 483
Comparative Treatment Failure Rates of Respiratory Fluoroquinolones in the Treatment of Community-Acquired Pneumonia: An Analysis of National Representative Claims Database : 484
Urinary Albumin Secretion in Type 2 Diabetes Patients (T2DM) with Albuminuria Treated with Sitagliptin as Add-On Therapy to Metformin: A Real-World Data Study : 485
Use of High Dimensional Propensity Scores to Control for Confounding in Assessing the Association between Bone Density Screening and Hip Fracture Risk : 486
On the Use of Propensity Score Method in Case of Rare Exposure : 487
Marginal Structural Model Simulation: the Effect of Omitting a Variable from the Outcome Model When It Is Present in the Numerator Model : 488
Developing Alerting Thresholds for Active Drug Safety Monitoring : 489
Cognitive Health, Willingness to Live, and Social Support but Not Physical Function May Be the Source of Healthy User Bias : 490
Value of Information Methods for Choice of Study Design : 491
Outcomes of Outpatient Integrated Medical Care Services across Times in a Medical Center : 492
ENCePP-HTA Working Group 2014 Survey of Members Experience in Conducting Research to Support HTA : 493
Medication Safety Improvement in Patients Transferred from Emergency Room to Medical Wards by Initiating Medication Reconciliation : 494
The Effectiveness Evaluation of Lasix, Albumin, and Both Used in Liver Disease Patients with Ascites : 495
Accounting for Treatment Complexity in Propensity Score Estimation: Case Study From T2DM : 496
A Propensity Score Matched Cohort Study to Measure the Effects of Orlistat or Bariatric Surgery on Health Outcomes in a General UK Population Sample : 497
Indirect Comparison of Meta-Analysis Findings on Adverse Treatment Outcomes: Impact of Trial Heterogeneity and Effect Measure Selection : 498
Comparative Effectiveness of Contemporary Adjuvant Chemotherapy Options among Older Rectal Cancer Patients : 499
Reduced Mortality in Thai Peritoneal Dialysis Patients Using Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Propensity Score Analysis : 500
Incidence of Diabetes Complications in Patients on Insulin Analogues Against Those on Human Insulin : 501
Radiographic and Endoscopic Diagnostic Workup around Initiation of Oral Bisphosphonates : 502
Using Refill Information to Improve the Performance of Preference-Based Instrumental Variables : 503
The Impact of Insulin Glargine vs. Human Insulin Use on Cancer Incidence : 504
Acute Pancreatitis in Type 2 Diabetic Patients Treated with Dipeptidyl Peptidase-4 (DPP-4) Inhibitor: A Population-Based Nested Case-Control Study : 505
Risk of Spontaneous Bacterial Peritonitis Associated with Gastric Acid Suppression : 506
Negative Control Study on the Risk of Acute Myocardial Infarction Associated with the Use of Antibiotics Using a US Database : 507
Does Use of Non-Steroidal Anti-Inflammatory Drugs Affect the Risk of Incident Active Tuberculosis Disease? A Nested Case Control Study on a National Health Claim Database : 508
Does Systemic Corticosteroids Use Increase the Risk of Incident Active Tuberculosis Disease? A Nested Case Control Study on a National Health Claim Database : 509
Mortality of Hydroxyethyl Starch Versus Dextran for Resuscitation in Intensive Care : 510
Effect of Topical Steroids on the Eye : 511
Severity of Stroke in Women Using Oral Contraceptives : 512
A Pilot Study on the Impact of Severe Photosensitivity Reactions Linked to Topical Ketoprofen in Europe : 513
Bisphosphonate (BP) Treatment and Renal Impairment (RI) in Women with Postmenopausal Osteoporosis (PMO) in UK : 514
Antipsychotic Drug and Seizure Risk among Patients with Psychotic or Mood Disorder in Taiwan : 515
An Observational Study of Upper Gastrointestinal Tract Bleeding Events in Patients Taking Duloxetine and Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): A Case-Control Analysis : 516
Fracture Risk among Depressed Patients Initiating SNRIs vs SSRIs Antidepressants : 517
Lamotrigine and the Risk of Severe Cutaneous Adverse Drug Reactions: A Nationwide Cohort Study : 518
Use of Low-Dose Aspirin and Prostate Cancer Risk : 519
Anti-Epileptic Drug Prescriptions and Attempted and Completed Suicide in Young Adults : 520
Association between Inhaled Corticosteroid Use and Diabetes & Other Endpoints in Chronic Obstructive Pulmonary Disease (COPD) : 521
Comparative Safety Profiles of Bevacizumab, Ranibizumab and Pegaptanib in the Treatment of Age-Related Macular Degeneration: the Analysis of the WHO Database of Adverse Drug Reactions : 522
Upper Gastrointestinal Bleeding in Patients with Schizophrenia in the United States : 523
Diabetes Drugs and Acute Pancreatitis: A Systematic Review of Observational Studies : 524
Total Cholesterol Level and Risk of Gastrointestinal Bleeding for Patient Taking Warfarin : 525
The Risk of Acute Asthmatic Attacks Associated with Different Dosage Forms of Non-Steroidal Anti-Inflammatory Drugs: A Self-Controlled Case Series Study : 526
Adverse Drug Reactions in Hospitalized Patients: A Comparative Study of Intensive Care and General Care Units : 527
Potential Drug-Drug Interactions in Oncology Patients Receiving Anti-Cancer Drugs in a Tertiary Medical Centre in Taiwan : 528
Psychiatric Health Care Utilisation and Related Costs in Newly Diagnosed Patients with Autism Spectrum Disorder (ASD) in Quebec (Canada) : 529
The Positive False Discovery Rate Method to Control the Multiplicity Problem in Pharmacovigilance: the SAFEGUARD Project : 530
Rifampicin-Associated with Thrombocytopenia in Dose Dependent Manner during Pulmonary Tuberculosis Treatment: A Case Report : 531
Drug Induced Liver Injury during TB Treatment in Indonesia : 532
Utility of Social Media Surveillance for Drug Safety and Signal Detection Purposes : 533
Exploring Adverse Event Reporting Patterns of Newly Approved Anti-Cancer Drugs in the Japanese Adverse Drug Event Report (JADER) Database : 534
Bisphosphonate Therapy and Osteonecrosis of the Jaw: A Case/Non-Case Study in the French National Pharmacovigilance Database : 535
Dopamine Agonists: Time Pattern of Adverse Effects Reporting in Australia : 536
Analysis of Safety Profiles between Iodinated Contrast Media and Anaphylaxis Based on Korea Adverse Event Reporting System : 537
Knowledge, Perception Attitude About Adverse Drug Reaction (ADR) and ADR Reporting Among Pharmacy Students’ in Malaysian Private University : 538
Side Effects Associated with Antiretroviral Therapy (ART) in Nepal : 539
Case Review of Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents : 540
Acute Topical β-Blocker Exposure in Asthma: Meta-Analysis of Controlled Clinical Trials : 541
Cases of Anaphylaxis Associated with the Use of Drugs: Analysis of a Pharmacovigilance Database : 542
Medications Prescribed and Occurrence of Falls in Inpatient Setting : 543
Common Causative Agents of Nephrotoxicity in a Regional Pharmacovigilance Center Based on an Academic Hospital in Korea, 2009-2013 : 544
Baseline Risk Factors for Cardiovascular Events: Differences between the USA and Russia in a Study Population of Combined Oral Contraceptive Users : 545
Improving Knowledge, Attitude and Practice of Pharmacovigilance among Traditional Medicine Practitioners in Lagos State, Nigeria : 546
Adverse Drug Event of Hospitalized Patients from Multi-Hospitals in Thailand : 547
Analysis in Adverse Reactions of Radiocontrast Agent Using Association Rule Mining in Regional Pharmacovigilance Center : 548
Use of Social Media in Pharmacovigilance: Testing the Waters : 549
A Comparison of Active Adverse Event Surveillance Systems Worldwide : 550
Using New Information and Communication Technologies (ICT) in Pharmacovigilance: Results of a 2 Waves Survey Conducted in France in 2012 and 2013 : 551
MIHARI – Medical Information for Risk Assessment Initiative Year 5 : 552
Adverse Reactions of Cardiovascular Drugs in Ukraine in 2011-2012 : 553
Are Patients Ready to Take Part in the Pharmacovigilance System – A Portuguese Preliminary Study Concerning Drug Reaction Reporting : 554
Analysis of Adverse Drug Reactions in Hanyang Univ. Hospital Drug Safety Center : 555
A Comparative Analysis of Adverse Drug Reactions: Pre- and Post Regional Pharmacovigilance Center in a Single Tertiary Hospital : 556
Evaluation of Statistical Measures for Adverse Drug Interaction Surveillance : 557
Study of Patients’ Potential as a Source for Spontaneous Reporting Systems in Bulgaria : 558
Sample Size Calculations for Comparative Pharmacoepidemiology Surveillance Studies in Healthcare Databases : 559
Pharmacovigilance Reporting from Saudi Hospitals: Survey of Pharmacovigilance Coordinators : 560
Potentially Inappropriate Medications Defined by STOPP Criteria on Nursing Home Residents of a Teaching Hospital in Taiwan : 561
The Effectiveness Evaluation of CPOE Drug Alerting System in NSAIDs Prescription for Patients with Renal Impairment : 562
Evaluation of the Relationship between BMI, Body Fat Percentage and Waist to Hip Ratio in Healthy Educated Young Indians : 563
The Effectiveness of Varenicline Medication Guide for Conveying Safety Information to Patients: A 3-Year REMS Assessment Survey : 564
Real World Utilization and Management of Adverse Events in Patients Treated with Direct Acting Antivirals (DAAs) in a European Cohort of Chronic Hepatitis C (CHC) Patients : 565
Management of Drug-Drug Interaction Alerts for Clinical Decision Support in Outpatients : 566
Ten Years Retrospective Review of Legal Warnings in Thailand : 567
Hypersensitivity Reactions to Andrographis Paniculata Reported to the Health Product Vigilance Center (HPVC) in Thailand : 568
A Review on Quality Surveillance Results of Cosmetics in Taiwan : 569
Conditional Approval from CHMP Is Associated with Increased Phase IV Epidemiology Study Commitments : 570
The Effect of Acquisition with the Outcome of Marketing Authorization Applications of New Active Substances Submitted to the EMA : 571
Case Study on a Violation of the Pharmaceutical Affairs Act: Illegal Commission of the Packing Processing of Medicinal Products to a Food Factory : 572
Acid-Suppressive Drug Use during Pregnancy and the Risk of Atopic Dermatitis: A Crossover Study Within the Clinical Practice Research Database : 573
Association between Antibiotic Use and Birth Defects Among Women Who Had Urinary Tract Infections in the First Trimester of Pregnancy : 574
Lamotrigine Use in Pregnancy and Risk of Orofacial Cleft, an Update of EUROCAT Lamotrigine Study : 575
Selective Serotonin Reuptake Inhibitor Use in First Trimester Pregnancy and Risk of Congenital Anomalies: A Register-Based Study in 12 European Countries : 576
Direct-from-Patient Information on Medication Use: PROTECT Pregnancy Study Results : 577
Discontinuation of Antipsychotic Medication in Pregnancy: A Cohort Study : 578
Trends in the Use of Anti-Epileptic Drugs during Pregnancy in the Netherlands : 579
Outcomes of Opioid Use in Pregnancy: A Danish Population-Based Study : 580
Birth Outcomes after Exposure to Mebendazole and Pyrvinium During Pregnancy – A Danish Nationwide Cohort Study : 581
NSAID Use during Pregnancy: Maternal Characteristics and Prescription Patterns. A Nationwide Cohort Study : 582
Combining Adverse Perinatal and Pregnancy Outcomes Using a Latent Trait Model : 583
Selective Serotonin Reuptake Inhibitors and Congenital Heart Anomalies: Comparative Cohort Studies : 584
Lithium Prescribing during Pregnancy: A UK Primary Care Database Study : 585
Parental Exposure to Folic Acid Antagonists During Reproductive Age in a National Sample : 586
First Results of the Nationwide pREGnant Register in the Netherlands : 587
Validation of Major Congenital Malformations (MCMs) in Infants of Mothers with Chronic Inflammatory Arthritis (cIA) and Psoriasis (PsO) : 588
Epidemiology of Pre-Existing Diabetes in Pregnancy from 2000-2006 among Medicaid Patients in 29 US States : 589
Internet Advertisement Methods Provide Highest Levels of Recruitment to a Pilot Study of Self-Reported Medication Use and Pregnancy Outcomes : 590
Risks Versus Benefits of Medication Use During Pregnancy: What Do Women Perceive? : 591
Creating a Pregnancy Register for a UK Population : 592
Evaluation of Medication Use During Pregnancy in the Mini-Sentinel Distributed Database : 593
Developing a Systematic Approach to Safer Medication Use during Pregnancy: Summary of a Centers for Disease Control and Prevention-Convened Meeting : 594
Female Kidney Transplant Patients Taking Mycophenolate Analysis in a Southern Taiwan Hospital : 595
Second Generation Antipsychotics and Risk of Type 2 Diabetes in Publicly Insured Children and Adolescents : 596
Attention-Deficit/Hyperactivity Disorder (ADHD) Pharmacological Treatment and Its Effect on Accident and Emergency Admission Due to Injury: A Self-Controlled Case-Series Study : 597
Antidepressants and Risk of Suicide or Self-Harm in Canadian Youth: A Study Involving a Common Data Model in Quebec and British Columbia : 598
Trend in the Prescribing of Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study from the Large-Scale Pharmacy Database : 599
Does Physicians’ Treatment of Pediatric Depression Reflect Evidence-Based Practice? Findings from a National Sample of Privately Insured Children and Adolescents : 600
Development of a Novel Approach to Assess Psychotropic Polypharmacy in Administrative Databases : 601
Does a Cardiovascular Event Change Adherence to Statin Treatment in Patients with Type 2 Diabetes? A Matched Cohort Design : 602
Factors Associated with Patients’ Adherence to Antihypertensive Drug Classes in the UK : 603
Factors Associated with β-Blocker Initiation and Discontinuation among Seniors with Heart Failure (HF) : 604
A Cross Country Comparison of the Impact of Cost-Sharing Policies on Adherence to Prescription Medicines : 605
Primary Care Prescriptions and Subsequent Pharmacy Dispensing: A Population-Based Study : 606
Statin Adherence and Treatment LDL-Cholesterol Response in Type 2 Diabetes Patients : 607
Effect of Long-Term Aspirin Use on the Risk for Neovascular Age-Related Macular Degeneration : 608
Preadmission Non-Steroidal Anti-Inflammatory Drug Use and 30-Day Stroke Mortality : 609
Chemoprevention of Esophageal Adenocarcinoma among Patients with Barrett's Esophagus : 610
Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study : 611
Impact of Dose and Duration of Oral Glucocorticoid Therapy on the Risk of Incident Type II Diabetes in Patients with Rheumatoid Arthritis : 612
Use of Glucocorticoids and Postoperative Bleeding after Gastric Bypass Surgery : 613
Statistical Natural Language Processing Can Accurately Identify Venous Thromboembolism (VTE) Events from Narrative Electronic Health Record Data : 614
Validity of Current Procedural Terminology (CPT) Codes and Natural Language Processing of Infusion Notes to Identify Outpatient Infliximab Infusion : 615
Linguistic Variability and Clinical Terminology in a Large Dutch General Practitioners Database : 616
Generating and Evaluating a Propensity Score Model Using Textual Features from Electronic Medical Records : 617
Handling Missing Exposure: A Simulation Study : 618
Assessment of Daily Dose of Domperidone in the Clinical Practice Research Datalink (CPRD) Using Multiple Information Sources : 619
Impact of Direct-To-Consumer Advertising on Asthma Prescriptions : 620
Lessons Learned on the Design of European Post Authorisation Safety Studies (PASS): Review of 18 Months of PRAC Oversight : 621
Hospital Based Electronic Medical Record Databases in China : 622
Development of Thailand Rational Drug Use Indicators : 623
Prevalence of Suboptimal Processes of Care Prior to Hospitalisation : 624
Understanding Patterns of Drug Utilization Studies (DUS) Requested By the European Medicines Agency (EMA) : 625
Comparison of Clinical Measures between Those with and Without a Diagnosis of Diabetes among Patients Prescribed Antidiabetic Drugs Within the Humedica EHR Database : 626
Patterns and Determinants of New First-Line Antihyperglycaemic Drug Use in Patients with Type 2 Diabetes Mellitus : 627
Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized Studies : 628
Incidence of New Onset Type 2 Diabetes (T2DM) with Seroquel XL™ in Primary Care in England: Results from an Observational Post-Marketing Cohort Study : 629
Glitazone Antidiabetics and the Risk of Parkinson's Disease : 630
Postmarketing Evaluation of the Safety of Saxagliptin: An Interim Analysis : 631
Comparative and Clinical Effectiveness Studies Based on Taiwan National Health Insurance Research Database : 632
Confirmation of Medical Events (ME) Identified from Existing Electronic Databases in Pharmacoepidemiology (PE) Studies : 633
Drugs and Devices: Challenges and Opportunities for the Evaluation of Combination Medical Products : 634
HOT, HOT, HOT and Getting HOTTER?- Climate Change and Pharmacoepidemiology : 635
How Do We Overcome Challenges of Diverse Views in Multi-Displinary Collaboration on CER? : 636
Improving the Science of Regulatory Decision-Making – Advances in 2013/2014 : 637
International Collaboration on Pharmacogenomics in Epidemiology Research : 638
Lithium Treatment and Risk for Dementia Among Patients with Bipolar Disorder : 639
Incidence of Antipsychotic Use in Relation to Diagnosis of Alzheimer's Disease among Community-Dwelling Persons: Nationwide Population Based Study : 640
Psychotropic Use among Patients with Dementia Receiving Donepezil in Japan : 641
Comparative Risk of Pneumonia among Different Cholinesterase Inhibitors : 642
Comparative Effectiveness of Antiepileptic Drugs in Adult Patients with Epilepsy : 643
Recent Trends in Antiepileptic Drug Prescribing in UK Primary Care : 644
Trends of Substance Misuse and Pharmaceutical Treatment Recorded in England and Wales Primary Care (1994-2012) : 645
Withdrawn by Author : 646
Effect of Facility Opioid Treatment Availability on Opioid Analgesic Overdose Deaths : 647
The Impact of Opioid Substitution Therapy on Mortality Post-Release from Prison: A Retrospective Data Linkage Study : 648
Treatment Utilisation and Retention with Opioid Substitution Therapy between 2001 and 2010: A Comparison of Buprenorphine and Methadone Users : 649
The Misuse, Abuse and Diversion of Opioid Replacement Therapies (ORT): A Study of Street Abusers : 650
When To Conduct Probabilistic Linkage vs. Deterministic Linkage? A Simulation Study : 651
Performance of Methods for Linking Registry Data to Insurance Claims When Unique Identifiers Are Unavailable : 652
Comparing Validity of Methods to Select Appropriate Cutoff Weight for Probabilistic Linkage Without Unique Identifiers : 653
Incorporating Linked Outpatient Data to Improve Confounding Control in a Study of In-Hospital Medication Use : 654
Predicting Linkage Within a Validated Algorithm That Identifies Mother-Infant Pairs Within the Medicaid Analytic EXtract (MAX) Database : 655
Accounting for Outcome Misclassification in Pharmacoepidemiologic Studies : 656
Five-Year Safety Results from the ENCORE Registry: Malignancies in Patients with Crohn's Disease Treated with Infliximab, Standard Therapy, or Switched from Standard Therapy to Infliximab : 657
Evaluation of Cancer Risk Following Use of Becaplermin, a Topical Platelet-Derived Growth Factor : 658
Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Risk of Non-Hodgkin's Lymphoma (NHL): A Systematic Review and Meta-Analysis : 659
Calcium Channel Blockers and Cancer Risk Using the UK CPRD : 660
Spironolactone and Incidence of Cancers: A Propensity Score Matched Cohort Study in the Clinical Practice Research Datalink (CPRD) : 661
Use of Statins and Prostate Cancer Mortality : 662
Effectiveness of Herpes Zoster Vaccination for Prevention of Post-Herpetic Neuralgia among Individuals with Herpes Zoster : 663
Herpes Zoster Infection Risk in Auto-Immune and Inflammatory Diseases: Implications for Vaccination : 664
Utilization of Nordic Countries National Registries to Monitor the Impact of HPV Vaccination : 665
Accuracy of Administrative Claims Data to Identify Dose Specific Rotavirus Vaccination Information: Implications for Studies of Vaccine Safety : 666
Narcolepsy and Pandemic H1N1 Vaccine: A Simulation Study to Explore the Effect of Bias : 667
Safety of Seasonal Influenza Vaccination in Solid Organ Transplant Recipients : 668
Modelling the Predicted Net Impact of Contraindication: the Example of Glaucoma Treatment : 669
Patients’ Preferences for Benefits and Risks of Anticoagulant Therapy: A Discrete Choice Experiment (DCE) : 670
Comparing Incremental Net Benefit (INB) of Apixaban, Dabigatran, Rivaroaxaban, and Warfarin in Patients with Atrial Fibrillation (AF) : 671
Comparison of ATRIA and CHA2DS2-VASc Risk Stratification Schemes for the Prediction of Stroke in the Individual Patient with Atrial Fibrillation and the Impact on Treatment Decisions : 672
Testosterone Laboratory Testing and Testosterone Supplementation Use among Adult Males in Denmark : 673
Time-Dependent Impact of Pre-Infarction Angina Pectoris and Intermittent Claudication on Mortality Following Myocardial Infarction as Measures of Inherent Local and Remote Ischemic Preconditioning: A Danish Nationwide Cohort Study : 674
The Common Data Model: Lessons from Past Projects and Ongoing Initiatives : 675
Comparisons in Pharmacoepidemiology: New Challenges and Limitations of Current Approaches : 676
How to Bridge the Gap between Requirements of Regulatory and Health Technology Assessment Authorities for Post Authorization Studies? Examples from Europe and Asia : 677
Multi-National Pharmacoepidemiological Studies in Asia - Methodological Challenges and Potential Cross-Continental Collaboration : 678
Special Issues in Pharmacovigilance in Emerging Countries : 679
The Patient's Voice in the Heart of BRACE (Benefit-Risk Assessment, Communication and Evaluation) : 680
Using Pharmaceutical Data for Evaluating Medicines Policy and Informing Quality Use of Medicines : 681
Combination Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study : 682
Impact of a Metoprolol Shortage on Post-Myocardial Infarction beta-Blocker Utilization : 683
The Use of Oral Isotretinoin in France: Assessment of Appropriate Use as a Second Line Treatment : 684
Impact of Abuse-Deterrent OxyContin on Prescription Opioid Utilization in the United States : 685
Survival of Elderly Australian Men Initiating Hormone Therapy for Prostate Cancer : 686
Genomic Determinants of Prognosis in Esophageal Adenocarcinoma: Using Computational Methods to Account for Gene-Gene Interactions : 687
Clinical Factors Associated with Prescription Filling of Mood-Stabilizers in Bipolar Disorder – A Population-Based Cohort Study : 688
Databases in Asia: The Potential for Distributed Network Approach : 689
Realistic Power Estimation for New User, Active Comparator Studies: An Empirical Example : 690
Use of Thiazolidinedione and Risk of Urothelial Cancer among Taiwan Diabetes Patients : 691
Comparing the Risk for Atrial Fibrillation in Patients with Diabetes Initiating Metformin or Sulfonylureas: A Nationwide Population-Based Cohort Study in Taiwan : 692
Statins and Risk of Pulmonary Complications and Mortality after Gastric Bypass Surgery : 693
Use of N-Methylthiotetrazole (NMTT) - Cephalosporin Antibiotics and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study : 694
The Risk of Acute Liver Injury among Users of Antibiotic Medications in the PROTECT Project: The Results of a Nested Case-Control Study Using European Outpatient Healthcare Data : 695
A Structured Database Approach for Addressing Pharmacoepidemiologic Research Needs Concerning Cancer : 696
Increasing Risks of Stroke in Oral Cancer Patients Treated with Radiotherapy or Chemotherapy: A Nationwide Cohort Study : 697
Algorithm to Identify Malignant Lymphoma Patients Extracted from an Electronic Hospital Database and Its Application in Japan : 698
The Disproportionate Analysis of Intravenous Iron-Containing Medicines Related Adverse Reactions in Taiwan : 699
Use of Antihypertensive Drugs and Risk of Skin Cancer : 700
Cancer Prognosis Following the Usage of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Lung Cancer Patients with Hypertension History : 701
Stroke Epidemiology in China over the Past Ten Years, a Study on Subtype Distribution and Case Fatality : 702
The Effect of Using Statin for Cardiovascular Prevention in Peritoneal Dialysis Patients : 703
Statin Use and Risk of New-Onset Diabetes in the Young Population with Hyperlipidemia : 704
Statin Use and the Risk of Incident Diabetes Mellitus: A Population-Based Retrospective Cohort Study in Taiwan : 705
ACE-Inhibitors and the Risk of Urinary Tract Infections: Comparison of a Case-Crossover and Prescription Sequence Symmetry Design : 706
Discontinuation of Angiotensin Converting Enzyme Inhibitors (ACEIs) as a Potential Marker for Adverse Drug Reactions (ADRs) : 707
Epidemiology of Psoriasis in Japan: Results from a Descriptive Study Using National Database : 708
Risk of Cardiac Valve Disorders with Use of Bisphosphonates : 709
Marginal Structural Model (MSM) to Estimate the Effect of Cumulative Osteoporosis Medication (OPM) on Serious Infection (SI) Using Claims Data : 710
Case Report: Stevens-Johnson Syndrome Following Exposure to Valproate : 711
Co-Morbid Medical Conditions in Vascular Dementia: A Case-Control Study : 712
Effectiveness and Safety of Aspirin in Taiwan Special Population : 713
Analysis of Adverse Drug Reactions of Antiepileptic Drugs by Using Spontaneous Reporting System in Medical Center in Taiwan : 714
Risk of Hip Fractures Associated with Benzodiazepines: Common Methodology But Different Results in a Multi-Site Cohort Study. The PROTECT Project : 715
No Impact of Adjusting for Lifestyle Factors or General Practice on Risk Estimates for the Association between Antidepressants and Hip/Femur Fracture : 716
Antidepressant Use and the Risk of Hip Fracture: A Self-Controlled Case Series Approach in Two Primary Care Databases : 717
Evaluation of “Pre-Treated” Bipolar Disorder Patients Receiving Atypical Antipsychotics in the UK Using an Electronic Health Record Database : 718
Deprivation and Cancer Incidence in Southern Europe: A Nation-Wide Ecological Study : 719
Antidepressants and Valvular Heart Disease: A Nested Case-Control Study in Taiwan : 720
Distinguishing an Optimal Risk Modeling Framework for Predicting Adverse Events : 721
Safety of GlaxoSmithKline's Inactivated Adjuvanted (AS03) A/H1N1pdm09 Pandemic Influenza Vaccine in Solid Organ Transplant Recipients : 722
Comparative Safety of Antimuscarinics among Adults in the United States, 2000–2011 : 723
Comparative Risk of Post-Operative Mortality between Taiwan Dialysis and Non-Dialysis Patients Receiving First-Time Surgery : 724
Factors Associated with Exposure of Potential Interactions between Chinese Herbal Medicines and Western Medications : 725
Utilization of Immunosuppressive Drugs in Post-Heart Transplant Recipients in Taiwan : 726
Association between Inhaled Long-Acting beta-2-Agonists and the Risk of Acute Myocardial Infarction: A Methodological Comparison of Two Databases : 727
Long-Acting beta Agonist Containing Therapies and the Risk of Serious Adverse Events in Subjects with Persistent Asthma : 728
Concurrent Use of Chinese Herbal Products Among Hormonal Users Aged 55-79 in Taiwan: A Population-Based Study : 729
Using Oncology Electronic Medical Records in the Study of Non-Melanoma Skin Cancer in the United States: Opportunities and Challenges : 730
Validating a Multiple Myeloma Algorithm Using a SEER Tumor Registry and Administrative Data : 731
Risk of Mortality with Venous Thromboembolism in CPRD GOLD: The Impact of Using Linked Data : 732
Identification of Heart Failure by Diagnoses and Cardiac Tests in a U.S. Electronic Health Records Database : 733
Validation of Major Adverse Cardiovascular Events (MACE) in US Claims Databases : 734
Concordance of Myocardial Infarction (MI) between Medicare Administrative Data and Physician Review Panel. The Atherosclerosis Risk in Communities (ARIC) Study : 735
Comparing the Influence of Month of Birth and Gender in Two Academic Years on Attention Deficit Hyperactivity Disorder Diagnoses (ADHD) Among Children in the Health Improvement Network (THIN) UK Data : 736
The Surveillance of Metoclopramide-Induced Extra-Pyramidal Symptoms and Movement Disorders Reported in Samsung Medical Center in Korea : 737
Osteoporosis in the Community: Findings from a Novel Computerized Registry in a Large Health Organization in Israel : 738
What Does Natural Language Processing Add to the Structured Data Available in Medical Records? : 739
Risk of Hospitalization and HealthCare Cost Associated with Diabetic Complication Severity Index in Taiwan's National Health Insurance Research Database : 740
Validation of Serious Hospitalized Infection Events in US Claims Databases : 741
Evaluation of Methods for Identifying Chemotherapy Induced Febrile Neutropenia among Cancer Patients in Denmark : 742
How Far Is Estimated Creatinine Clearance (eClcr) and Estimated Glomerular Filtration Rate (eGFR) from Measured Creatinine Clearance (mClcr) in Taiwanese : 743
A Review of Dental Adverse Events Using the FDA Adverse Event Reporting System : 744
Socio-Economic Status and Hip Fracture Risk: A Region-Wide Ecological Study : 745
Socio-Economic Status and the Risk of Developing Osteoarthritis: A Region-Wide Ecological Study : 746
Acute Mortality among Psychiatric Patients with Acute Agitation Using a Japanese Hospital Database : 747
Under-Recording of Endometriosis in the Health Improvement Network (THIN) Primary Care Database: A Validation Study : 748
Performance of an Algorithm for Identifying Primary Hypocalcemia in Commercial Health Plan Claims Data : 749
Predicting the Need for Prolonged Mechanical Ventilation Following the First Hospital Admission Due to Chronic Obstructive Pulmonary Disease with Acute Exacerbation : 750
Performance of an Algorithm for Identifying Serious Dermatologic Adverse Events in Commercial Health Plan Claims Data : 751
A Normalization Method for Clinical Laboratory Test Results between Distributed Electronic Healthcare Databases : 752
The Predictive Values in Validation Studies: Misleading Statistics? : 753
A Novel Broadly Applicable Risk Score for Predicting Mortality of Patients with Circulatory System Diseases Within Hospitalization Duration : 754
Applying STROBE in Renal Journals, Is There Any Difference in the Quality of Reporting Observational Studies? : 755
An Evaluation of Sequential Analysis Methods for Active Drug Safety Surveillance Using Observational Data : 756
Considerations for Using Electronic Medical Record Data for Pharmacoepidemiology : 757
Impact of Varying Control Moment Selection in a Case-Crossover (CCO) Study on Antidepressant Drug (AD) Use and Hip/Femur Fracture (HFF) in PROTECT : 758
Study Designs in Pharmacoepidemiologic Studies on Electronic Healthcare Databases: A Systematic Review : 759
RCT Participants and Real Life Drug Users: A Population-Based Cohort Study : 760
MM Optimization in Massive Observational Analysis : 761
Understanding of the Clinical Course of Breast Cancer in Japanese Women Using Health Insurance Claims Database : 762
Simvastatin and Its Potential Drug Interactions: An Analysis of Safety Signal Based on FDA AERS Database : 763
Validity of Coding and Descriptive Epidemiology of Rheumatoid Arthritis in Catalonia, Spain: A Population-Based Cohort Study : 764
Lessons Learned from a Survey for Hospitalized Influenza Using a Japanese Administrative Database : 765
The Association of Neovascular Age-Related Macular Degeneration with Cardiovascular Diseases: A Study Using the NHIRD in Taiwan : 766
Race-Specific Prevalence and Risk Factors for Cutaneous Psoriasis in a U.S. Population-Based Cohort : 767
Interactive Web-Based Tool for Cohort Creation and Disease Outcome Feasibility : 768
Comorbidities in Patients with Thyroid Cancer Evaluated Using US Administrative Claims Data : 769
Suspected Adverse Drug Reactions Caused by Herb Ephedrae Case Study : 770
A Comparison between Chinese and US Electronic Health Records Database Structures : 771
Reducing the Manual Burden of Medical Record Review through Informatics : 772
Use of Hydroxyethyl Starch Solutions in Taiwan : 773
Impact of Subgroup Analyses and Adjustment by Stratification on Safety Signal Detection for Individual Case Reports : 774
Structured Assessment for Prospective Identification of Potential Safety Signals in Electronic Health Records : 775
Evaluating Survival Outcome for Chemotherapy in Advanced Lung Cancer Patients : 776
Incidence of Intussusception in Early Childhood in the Netherlands as a Baseline to the Introduction of New Rotavirus Vaccines : 778
Identification of Drug-Induced Liver Injury in Medical Information Databases Using the Japanese Diagnostic Scale : 779
Validation of Diagnostic Algorithms to Identify AIDS Status, Hepatitis C Infection, Alcohol Abuse and Illicit Drug Use in HIV Positive Individuals in the Database of the Regie de l'Assurance-Maladie du Quebec : 780
Signal Detection for Potential Drug-Drug Interactions Using Inpatient Electronic Health Records with Laboratory Data : 781
Flumazenil as Trigger Tool for Measuring Adverse Drug Events : 782
Clinical Burden of ANCA Associated Vasculitis : 783
Is Information on Medication Use and Occurrence of Drug Related Problems Obtained by Means of a Patient Questionnaire Useful When Conducting Clinical Medication Reviews in Older Patients? : 784
Performance of Claims-Based Algorithms for Identifying Thyroid Cancer in Commercial Health Plan Enrollees Receiving Antidiabetic Therapies : 785
Predictive Analysis for Identifying Post Stroke Spasticity Patients in UK Primary Care Data : 786
The Feasibility of Using Administrative Claims Data to Study Pure Red Cell Aplasia (PRCA) in a Cohort of Chronic Hepatitis C (CHC) Patients : 787
Validation of Diagnosis of Age-Related Macular Degeneration in a Computer Database of Primary Care : 788
Validation of Health Insurance Claims in Identification of Sudden Cardiac Death or Hospitalized Myocardial Infarction (MI) Death through US National Death Index (NDI) Search : 789
A Comparison of Disproportionality Analysis Methods in National Adverse Drug Reaction Databases of China : 790
Signal Detection from Spontaneous Reporting System: An Evaluation of Disproportionality Analysis in China : 791
Feasibility of Alternative Methods for Health Outcomes of Interest Algorithm Validation : 792
Validation of Clinical Diagnoses, Medication Use, and Health System Utilization in Taiwan's National Health Insurance Research Database : 793
What Can Affect the Agreement between Patient and General Practitioner Data on Medicine Use? : 794
Agreement between Patient and General Practitioner Data on Medicine Use : 795
Beyond Crude Cohort Designs: Large-Scale Adjustment Approaches for Pharmacoepidemiology : 796
Refill Variables in Administrative Claims Data – Potential Implications for Defining New Medication User Cohorts : 797
How to Combine Evidence in a Database Network : 798
Measuring Frailty Using Claims Data for Pharmacoepidemiologic Studies of Mortality in Older Adults: Evidence and Recommendations : 799
A Critical Review of Pharmacoepidemiological Observational Post-Authorisation Safety Study (PASS) Design Used in the European Union and Its Applicability in Latin America (LA) : 800
Bayesian Computation on Graphics Processing Units Expands the Reach and Practicability of Bayesian Methods in Pharmacoepidemiology : 801
Feasibility of Adjusted Parametric Methods to Model Survival Data as a Tool for Signal Strengthening: An Example in Modified Prescription-Event Monitoring (M-PEM) : 802
Calibration of Statistics from Observational Studies Using Control Drug-Outcome Pairs: Incorporating Uncertainty about Controls : 803
Use of a Bayesian Approach to Design and Evaluation of NCE2 : 804
Reporting of Confounding Bias in Observational Intervention Studies: Are We Making Progress? : 805
Withdrawn by Author : 806
Validation of Indonesian Version of Short Formulary-36 Questionnaire in Hypertension Patients : 807
Association between Hospitalizations Due to Cardiovascular and/or Neurologic Diseases and Exposure of High Alert Chinese Medications: Nested Case-Control Study : 808
Assessment of Affect of Geriatric Conditions on Activities of Daily Living in the Elderly : 809
The Risk of Geriatric Conditions in Patient with Diabetes Mellitus and Hypertension : 810
The Effectiveness and Safety of Febuxostat for Chronic Kidney Disease Patients with Gout and Hyperuricemia : 811
Non-Prescription Medicine Purchasing Behavior Among Community Pharmacy Patrons in Malaysia : 812
Outcomes of Earlier Use of Inhaled Corticosteroids among Patients Diagnosed with Moderate Chronic Obstructive Pulmonary Diseases : 813
Assessment on the Risk of Pneumonia Associated with Inhaled Corticosteroids in COPD Patients in Taiwan : 814
The Prescription Analysis of Sedative Hypnotics in Nursing Home of Hospital : 815
Assessment of Diabetic Care Pay-for-Performance Program : 816
Common Data Model Conversion in AsPEN for SCAN Project : 817
Evaluation of Drug Safety Monitoring System in the Republic of Armenia : 818
Framework Proposal for Post-Marketing Surveillance (PMS) from Taiwan National ADR Reporting Center : 819
The Association between Oral Fluoroquinolones and Incident Seizure Event : 820
Trastuzumab-Related Cardiotoxicity Among Breast Cancer Patients in Taiwan : 821
Withdrawn by Author : 822
Comparative Risk of Oral Ulcerations among Antipsychotic Users with Schizophrenia or Bipolar Disorder : 823
The Utilization of Pharmacovigilance Databases for the Safety of Health Products: A Systematic Review : 824
Adverse Drug Reactions Leading to Hospital Admissions: A Prospective Study : 825
Baseline Characteristics of COPD Clinical Trial Subjects: An Inter-Ethnic Comparison : 826
Pharmacoepidemiolgy Studies in China: Are There Gaps in Databases, Training Programs or Both? : 827
Psoriasis and the Risk of Myocardial Infarction: A Population-Based Cohort Study Using the Clinical Practice Research Datalink : 828
Psoriasis and the Risk of Stroke: A Population-Based Cohort Study Using the Clinical Practice Research Datalink (CPRD) : 829
Spontaneous Reports of Thromboembolic Events Associated with Cyproterone/Ethinylestradiol after Media Attention : 830
Bisphosphonate and Adverse Cardiovascular Events: Meta-Analysis of Randomized Placebo-Controlled Trials : 831
Potential Signals for Cardiovascular-Related Adverse Events with COX Inhibitor Use: Analysis of the WHO Global ICSR Database System (VigiBase) : 832
Temporal Changes in the Prescribing Propensity Following Safety Warnings : 833
A Comparison of Cardiac Event Rates in Patients with or Without Multiple Myeloma in the US : 834
Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients Compared to Non-Psoriatic Arthritis Patients : 835
Comparative Safety of NSAIDs on Myocardial Infarction According to the COX-2 Selectivity : 836
Risk of Aortic Aneurysm or Aortic Dissection Associated with Fluoroquinolone Therapy : 837
Ranibizumab Associated with Increased Risk of Ischaemic Stroke but Not Myocardial Infarct: A Self-Controlled Case Series Analysis : 838
Methods and Guidelines for Integrity of Multivariable Analysis of Real World (observational) Data : 839
Validity of Claims-Based Stroke Algorithms in Contemporary Medicare Data: REGARDS Study Linked with Medicare Claims : 840
Performance of ICD-10 Codes in a Computerized Hospital Database for Identification of Acute Coronary Syndrome : 841
Prevalence of Cardiovascular Risk Factors and Estimated 10 Year Cardiovascular Risk for Patients in the Febuxostat Versus Allopurinol Streamlined Trial (FAST) : 842
Cardiovascular Risk Management of Patients in the Febuxostat Versus Allopurinol Streamlined Trial (FAST) : 843
Incidence of Heart Failure: A Population-Based Study in General Practice Setting : 844
Risk of Death in a Cohort of Newly Diagnosed Heart Failure Patients : 845
Cardiac Dysfunction among Soft Tissue Sarcoma Patients in Denmark : 846
Risk of QT Prolongation Induced by Atypical Antipsychotics: A Case-Control Study : 847
Cardiac Adverse Events Associated with Macrolide and Fluoroquinolone Antibiotics : 848
Pulse Pressure and Stroke Risk: Development and Validation of a New Stroke Risk Model : 849
Impact of Concomitant Use of Proton Pump Inhibitors and Dual Antiplatelet Therapy on Recurrent Myocardial Infarction: A Population-Based Case Cross-Over Study : 850
Long-Term Evaluation of the Effectiveness of Warfarin Interactions Prescription Warning System in a Medical Center : 851
Use of Warfarin and Risk of Stroke and Mortality in Chronic Dialysis Patients with Atrial Fibrillation in Taiwan : 852
Risk of Peripheral Neuropathy for Dronedarone Compared to Other Antiarrhythmics : 853
Risk of New-Onset Diabetes in Users of Lipid Lowering Drugs (LLDs) : 854
Development of a Collaborative European Post-Authorization Safety Study (PASS) Program Examining Rivaroxaban Use in Routine Clinical Practice : 855
Comparative Safety of New Oral Anticoagulants in Nonvalvular Atrial Fibrillation – A Single Medical Center Experience : 856
Minor Bleedings and Associated Risk Factors Within Patients Initiating Warfarin Therapy: Population-Based Study : 857
Clinical Outcomes of Pharmacists Providing Medication Education to Inpatients New on Warfarin Therapy : 858
Comparing Individual Angiotensin-Converting Enzyme Inhibitors with Angiotensin Receptor Blockers on the Risk of Pneumonia: A Nationwide Cohort Study : 859
Does Use of Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Decrease the Risk of Incident Active Tuberculosis Disease? A Nested Case-Control Study on a National Health Claim Database : 860
Does Use of Calcium Channel Blockers Affect the Risk of Incident Active Tuberculosis Disease? A Nested Case Control Study on a National Health Claim Database : 861
Is Statin Use Associated with Reduced Risk of Incident Active Tuberculosis? A Population-Based Nested Case-Control Study : 862
Impact of Diuretic Use on Serum Urate Level in the Febuxostat Versus Allopurinol Streamlined Trial (FAST) : 863
Is There Less Interaction with Atorvastatin and Rosuvastatin? : 864
Early Intervention of Skin Toxicities by Panitumumab and Clinical Outcomes in the Clinical Setting : 865
Do Pharmaceutical Claims Accurately Reflect Oncology Prescribing Practice: Evidence from an Australian HER2+ Early Breast Cancer Cohort (HER2EBC) : 866
Analysis of Human Recombinant Somatropins, Erythropoietins and Granulocyte Colony Stimulating Factors in Pharmaceutical Formulations : 867
Hepatotoxicity with Pazopanib for Renal Cell Carcinoma in the Post-Approval Setting : 868
A Systematic Review of Progressive Multifocal Leukoencephalopathy Case Reports Associated with Monoclonal Antibody Treatment : 869
Adverse Reactions Associated To Biologics for Psoriasis in Brazil : 870
HER2 Positive Early Breast Cancer (HER2EBC): An Australian Patterns of Care Study : 871
Bypassing Agents and Risk of Thromboembolic Events in Patients with Hemophilia and Inhibitors : 872
Factors Associated with Denosumab Initiation among Postmenopausal Osteoporosis Patients in Medicare : 873
Safety Profile of Ophthalmic Biologics: Review of Safety Data : 874
Characteristics of Rheumatoid Arthritis Patients Initiating Abatacept Therapy : 875
Utilization Pattern of Tumor Necrosis Factor alpha Inhibitors among Patients with Rheumatologic Arthritis in Korea : 876
Drug Safety Evaluation of Linezolid Injection Inducing Thrombocytopenia : 877
Challenges of a Post-Authorisation Safety Study (PASS) in an Orphan Oncology Indication : 878
Assessment of Patient Characteristics of Selective Serotonin Reuptake Inhibitor (SSRI) Plus Add-On Treatment Users in a United States Claims Database : 879
Types of Adverse Reactions of Non-Steroidal Anti-Inflammatory Drugs. Multiclassificational Approach : 880
Effectiveness of Multidisciplinary Care for Chronic Kidney Disease Stage I to IV: An Experience of CCPC-CKD Program : 881
Pharmacist Role in Diabetes Clinical Care Program Certification (CCPC-DM) : 882
Characterization of Patients with Type 1 and Type 2 Diabetes and Availability of Clinical Measures Within the Humedica Research Database : 883
The Impact of Clinical Pharmacist on the Medicine Expenditure in the Surgical Intensive Care Unit : 884
Cost-Effectiveness Analysis between Rocephin® and Ceftrixone® in Hospitalized Patient with Community-Acquired Pneumonia : 885
Teaching Pharmacoepidemiology in the GCC Countries: Survey of Pharmacy Schools : 886
Experience of Joint Post-Authorization Safety Studies (PASS) through an Example : 887
Safety Practices of Compounded Sterile Parenteral Preparations: An International Cross-Sectional Study : 888
An Assessment of the Current Medication Safety Practices in the Primary Care Settings in Riyadh, Saudi Arabia : 889
Compounding Training in Singapore: Are Final Year Pharmacy Students Ready in Ensuring Quality and Safety of Compounded Medications? : 890
We've Got Your Clinical Data – What's in It for Clinicians? : 891
Analysis of Barriers to Patient Recruitment: A Poster Advertising Campaign for Two Online-Only Clinical Studies : 892
A Novel Approach to Pharmacogenomic and Pharmacoepidemiologic Evidence Synthesis for Predictive Analysis and Regulatory Decision-Making on Medical Device Performance : 893
Impact, in Real Life Conditions, of the Use of a Purifier Spray on Allergy Care in Dust Mite Allergic Subjects : 894
Comparative Safety of Endovascular and Open Surgical Repair of Abdominal Aortic Aneurysms in Low-Risk Patients : 895
Cardiac Resynchronization Devices with and Without Defibrillation: A Quantitative Systematic Review and Assessment of National Use : 896
Comparative Safety and Effectiveness of Robotic-Assisted Mitral Valve Repair : 897
The Selection of Prosthetics Aortic Valves for Elderly Medicare Patients from 2006 to 2011 – A Population Based Cross-Sectional Study : 898
Long Term Safety of Sacral Nerve Modulation in Medicare Beneficiaries : 899
Trend, Utilization, and Outcomes of Male Incontinence Devices : 900
Comparative Effectiveness of Robotic Device Assisted vs. Thoracoscopic Lobectomy : 901
Taiwan Post-Market Surveillance of Medical Devices in Recent 5 Years : 902
Anti-Coagulation After Hip or Knee Joint Replacement: Assessment of the Benefits and Risks in an Elderly Cohort : 903
12-Year Implantation and Survival Rates of Patients with Implantable Cardioverter-Defibrillator in Routine Clinical Practice Compared with the Background Population, and the Prognostic Impact of Age, Sex, and Comorbidity: A Danish Nationwide Population-Based Cohort Study : 904
Comparative Effectiveness of Peripheral Vascular Stents and Surgical Bypass for Critical Limb Ischemia in the Vascular Study Group of Greater New York : 905
How Do Routine Care Carotid Artery Stenting Patients Fare Compared to Those Enrolled in Trials? : 906
Use of Optional ICD-9-CM Articulating Surface Codes for Total Hip Arthroplasty in US Claims Data : 907
Hospital Volume and Outcomes for Total Hip Arthroplasty : 908
Evaluation of Implant Stabilization and Mobility in Total Knee Arthroplasty : 909
Creation and Use of a “Lag Time” Variable for Comparative Effectiveness Research Using Claims Data : 910
Identifying Important Sensitivity Analyses Empirically for Pre-Specification in CER Protocols : 911
Withdrawn by Author : 912
Risk of Spontaneous Abortion in Young Women Exposed to Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in the United Kingdom: An Observational Cohort Study : 913
Withdrawn by Author : 914
Risk of Microscopic Colitis during Use of PPIs, NSAIDs, beta-Blockers and Other Drugs : 915
A Descriptive Analysis to Compare the Occurrence of Myocardial Infarction (MI) in Testosterone-Treated and Untreated Hypogonadal Males and PDE5-Inhibitor Users : 916
Risk of Sudden Sensorineural Hearing Loss in Adults Using Phosphodiesterase Type 5 Inhibitors : 917
An Innovative Approach to Benefit-Risk Assessment Addressing Quality and Efficiency with Transformative Technology: Insights and Lessons from a Pilot Initiative : 918
Educational Intervention to Improve the Practice of Pharmacovigilance among Traditional Medicine Practitioners : 919
Natural Language Processing of Clinical Notes in Electronic Health Records to Improve Capture of Hypoglycemia : 920
Incidence Rate of Microscopic Colitis in the Netherlands : 921
The Positive Impact of Pharmacist on Appropriateness of Ambulatory Prescriptions in Medical Center : 922
Risk of Diabetes among Patients Exposed to Primary Androgen Deprivation Therapy for Clinically Localized Prostate Cancer : 923
Study of Ursodeoxycholic Acid Influence on Efficacy and Safety of Statin Therapy in Patients with Liver, Gall Bladder and/or Biliary Tract Diseases (the RAKURS Study) : 924
A Comparative Analysis of Signal Detection in Electronic Healthcare Databases vs. Spontaneous Reporting Databases : 925